• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

B
B Sørensen B.	-	EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS
b. d. Karim F.A.	-	ACQUIRED VON WILLEBRAND DISEASE IN A PATIENT WITH SYSTEMIC LUPUE ERYTHEMATOSUS
Baaklini C.	-	ASSESSMENT OF ACTIONS FOR IMPROVING PREVENTION OF THROMBOEMBOLIC DISEASE IN MEDICAL PATIENTS
Baas M.	-	A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR
Babaei M.	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
Babinska A.	-	THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Babos A.	-	REPLACING ORAL ANTICOAGULANTS WITH TINZAPARIN SODIUM IN PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY: SAFETY AND COST CONSIDERATIONS
Baccante G.	-	LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES
Bacchu S.	-	WHAT DO ELEVATED D-DIMER LEVELS MEAN IN PATIENTS WITHOUT VENOUS THROMBOSIS (VTE)?
Bacci M.	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
Bach R.R.	-	TISSUE FACTOR PROCOAGULANT ACTIVITY LEVELS IN HUMAN BLOOD ARE ELEVATED BY WARFARIN
Bach J.	-	FV LEIDEN, THE APOE GENOTYPE AND OTHER GENE POLYMORPHISMS IN PATIENTS UNDERGOING CARDIAC SURGERY
Bach R.R.	-	INCREASED CELL ASSOCIATED TISSUE FACTOR ACTIVITY FOLLOWING TOTAL KNEE ARTHROPLASTY
	-	STATINS INHIBIT LPS-INDUCED MONOCYTE-ASSOCIATED, BUT NOT PLATELET- OR MICROPARTICLE-ASSOCIATED TISSUE FACTOR (TF) EXPRESSION IN VIVO AND EX VIVO
Bachelot-Loza C.	-	THE RGDS SEQUENCE OF THE ANTICOAGULANT PROTEIN C (PC) CONTRIBUTES TO ITS ENDOTHELIAL CELL RECEPTOR (EPCR) BINDING
	-	EFFECT OF HIGH-DOSE APROTININ ON PLATELET FUNCTION AFTER NORMOTHERMIC CARDIOPULMONARY BYPASS IN CHILDREN CARDIAC SURGERY
Bachli E.B.	-	TRANSCRIPTOME ANALYSIS OF THE PAR-1 MEDIATED ACTIVATION PATHWAY IN HUMAN MONOCYTES AND INTERACTIONS OF ACTIVATED PROTEIN C
Bachoo P.	-	PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIC EVENTS IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY
	-	PLATELET ACTIVATION INCREASES WITH THE SEVERITY OF PERIPHERAL ARTERIAL DISEASE: IMPLICATIONS FOR CLINICAL MANAGEMENT
Bäck J.	-	FACTOR XII-MEDIATED CONTACT ACTIVATION OCCURS ON THE SURFACE OF THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP)-ACTIVATED PLATELETS
Bacoula C.	-	CIRCULATING LEVELS OF ADHESION MOLECULES AND MARKERS OF ENDOTHELIAL DYSFUNCTION IN ACUTE INFLAMMATION INDUCED BY PROLONGED BRISK EXERCISE: RAPID ENDOTHELIAL RECOVERY AND POTENTIAL BENEFICIAL EFFECTS
Bacovsky J.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Badenhorst P.N.	-	IDENTIFICATION OF TYPE 2M VON WILLEBRAND DISEASE BY DENSITOMETRIC ANALYSIS OF VON WILLEBRAND FACTOR MULTIMER PATTERNS
	-	CHARACTERISATION OF AN INHIBITORY ANTIBODY FRAGMENT TO HUMAN TISSUE FACTOR
	-	A NOVEL COMPLETE HIGH SHEAR RATE ARTERIAL THROMBOSIS AND BLEEDING MODEL IN BABOONS
	-	PERFORMANCE AND UTILITY OF A COST-EFFECTIVE COLLAGEN BINDING ASSAY USING TYPE III COLLAGEN
	-	CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Bader R.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
Badereddine L.	-	CLINICAL AND BIOLOGICAL ASPECTS OF VON WILLEBRAND DISEASE IN ALGERIA
Badger G.	-	EFFECTS OF ORAL (OC) AND TRANSDERMAL (TC) HORMONAL CONTRACEPTION ON COAGULATION FACTORS AND ACTIVATED PROTEIN C RESISTANCE: IMPLICATIONS FOR THROMBOSIS RISK
Badifard L.	-	INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Badimon L.	-	MODIFIED CRP ENHANCES PLATELET ADHESION AND THROMBUS GROWTH ON COLLAGEN
	-	BENEFICIAL EFFECTS OF DAILY OLIVE OIL CONSUMPTION IN THROMBOSIS. STUDIES IN NORMOLIPEMIC PIGS
	-	THROMBOXANE A2/PROSTAGLANDIN H2 RECEPTOR BLOCKER (S18886) SHOWS ANTITHROMBOTIC EFFICACY SIMILAR TO ASPIRIN PLUS CLOPIDOGREL IN STENT-INDUCED THROMBOSIS
Badimon J.J.	-	PLAQUE PROGRESSION AND REGRESSION IN ATHEROTHROMBOSIS
Badol P.	-	THIOSULFINATES MODULATE PLATELET ACTIVATION AND MONOCYTE FUNCTION BY REACTION WITH SURFACE FREE SULFHYDRYLS AND INTERNAL THIOL-CONTAINING PROTEINS
Bae S.	-	C936T MUTATION IN THE VEGF GENE AS AN INDEPENDENT RISK FACTOR FOR PATIENTS WITH SILENT BRAIN INFARCTION
	-	GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
Bae J.	-	THE RECEPTORS OF PROTEIN C ACTIVATION AND ACTIVATED PROTEIN C SIGNALING PATHWAYS ARE CO-LOCALIZED IN LIPID RAFTS OF ENDOTHELIAL CELLS
Bae S.	-	PROGNOSTIC SIGNIFICANCE OF THE POLYMORPHISMS IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR C677T) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) GENE IN EPILEPSY
Baekgaard N.	-	LOCAL THROMBOLYTIC THERAPY FOR ACUTE ILIOFEMORAL DEEP VENOUS THROMBOSIS IS EFFECTIVE AND PRESERVES VENOUS VALVE FUNCTION. A PROSPECTIVE ONE-CENTRE STUDY OF 86 CASES
Baeshko A.A.	-	HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOSIS IN BELARUS
Baeten K.M.	-	ENHANCEMENT OF SINGLE-CHAIN UROKINASE ACTIVITY BY PLATELET PROTEINS
Bafunno V.V.B.	-	A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS
Baghaipour M.	-	GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
	-	FACTOR VII GENOTYPE AND CLINICAL PROFILE IN 6 IRANIAN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY
Baghaipour M.R.	-	COMBINED FACTOR V AND VIII DEFICIENCY, A LARGE GROUP FROM IRAN
Baghaipour M.	-	GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
Baghli L.	-	CLINICAL AND BIOLOGICAL ASPECTS OF VON WILLEBRAND DISEASE IN ALGERIA
Baginski M.	-	VENOUS THROMBOEMBOLISM AND CANCER: THE PERCEIVE REGISTRY
Baglin T.P.	-	BIOCHEMICAL CHARACTERISATION OF ANTITHROMBIN BUDAPEST 3 (L99F)
	-	A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS
	-	ELEVATED ENDOGENOUS THROMBIN POTENTIAL (ETP) IS ASSOCIATED WITH AN INCREASED RISK OF A FIRST DEEP VENOUS THROMBOSIS BUT NOT WITH RECURRENCE
Baglin T.	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Bagoly Z.	-	TRANSIENT ACTIVATION OF BLOOD COAGULATION FACTOR XIII BY POLYMORPHONUCLEAR GRANULOCYTE ELASTASE
	-	DOWN-REGULATION OF ACTIVATED FACTOR XIII BY POLYMORPHONUCLEAR GRANULOCYTE PROTEASES WITHIN THE FIBRIN CLOT
Bahena A.	-	BISBUDIAME, AN ESTROGEN DERIVATIVE WITH AN ANTITHROMBOTIC EFFECT
Bahnson B.J.	-	THE CENTRAL LINKER OF CALCIUM- AND INTEGRIN-BINDING PROTEIN 1 FUNCTIONS AS A TETHER AND IS CRITICAL FOR BINDING THE CYTOPLASMIC TAIL OF THE INTEGRIN ALPHA IIB SUBUNIT
Bai X.	-	ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
Bai C.	-	VENOUS THROMBOEMBOLISM IN CHINA: A SINGLE-CENTER EXPERIENCE FOR 11 YEARS
Bai Y.	-	CROSS REACTION OF ANTIBODY AGAINST HELICOBACTER PYLORI UREASE B WITH PLATELET GLYCOPROTEIN IIIA AND ITS SIGNIFICANCE IN THE PATHOGENESIS OF ITP
Bai X.	-	CROSS REACTION OF ANTIBODY AGAINST HELICOBACTER PYLORI UREASE B WITH PLATELET GLYCOPROTEIN IIIA AND ITS SIGNIFICANCE IN THE PATHOGENESIS OF ITP
	-	EXPRESSION OF MT1-MMP IN HUMAN VASCULAR ENDOTHELIAL CELL LINES AND THE CONSTRUCTION OF ITS EUKARYOTIC EXPRESSION VECTOR
	-	PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
	-	QUANTITATIVE ANALYSIS OF GENE EXPRESSION FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS APPLICATION
	-	A HETEROZYGOUS MUTATION OF GPIIB IN PATIENT WITH GLANZMANN THROMBASTHENIA
	-	VEGF-C PROMOTE OF THE GROWTH AND ANGIOGENESIS IN NB4 CELL XENOGRAFT TUMOR
Bai B.	-	THROMBIN GENERATION PARAMETERS IN A PLATELET-POOR PLASMA MODEL SYSTEM AND THEIR USE IN PATIENTS WITH SINGLE FACTOR DEFICIENCY
Baibarina E.N.	-	APPLICATION OF AUTOLOGOUS RED BLOOD CELLS CONCENTRATE DERIVED FROM UMBILICAL CORD BLOOD FOR THERAPY OF ANAEMIC NEONATES
Baidya S.	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY IN INDIA - A SERIES OF 31 PATIENTS
	-	HEREDITARY DYSFUNCTIONAL FACTOR X IS THAT PASSOVOY FACTOR?
	-	MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
	-	NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA
Baik H.J.	-	IMMUNE TOLERANCE INDUCTION FOR KOREAN HEMOPHILIACS WITH INHIBITORS
Baila S.	-	PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION
	-	IN VIVO EFFECTS OF MURINE AND HUMAN APC
	-	NOVEL MODELS OF THROMBOPHILIA RESULT IN SPONTANEOUS PERIPHERAL THROMBOSIS AND PREGNANCY-RELATED COMPLICATIONS
Bailey K.R.	-	IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY
	-	RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) AMONG ACTIVE CANCER PATIENTS: A POPULATION-BASED CASE-CONTROL STUDY
Bailon O.V.	-	SYNERGISTIC EFFECT OF SMOKING ON PLATELET RESPONSIVENESS TO CLOPIDOGREL
	-	EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI
Baimuradova S.M.	-	ANTIPHOSPHOLIPID ANTIBODIES SPECTRUM IN WOMEN WITH RECCURENT FETAL LOSS SYNDROME
	-	PATHOGENETIC PROPHYLAXIS OF RECCURENT FETAL LOSS SYNDROME IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND GENETIC THROMBOPHILIA
	-	PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PREGNANT WOMEN WITH THROMBOPHILIA
	-	PROPHYLAXIS OF RECURENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA
Bajanova M.	-	SUCCESSFUL INHIBITOR-ELIMINATION W ITH RITUXIMAB IN ONE PATIENT WITH A CARRIER STATE FOR HEMOPHILIA A AND 4 PATIENTS WITH ACQUIRED HEMOPHILIA A
Bajc M.	-	EARLY HOME THERAPY AND OUTCOME AMONG 675 PATIENTS WITH PULMONARY EMBOLISM
Bajetta M.T.	-	DETERMINATION OF ANTI-ADAMTS13 AUTOANTIBODIES IN THROMBOTIC TROMBOCITOPENIC PURPURA (TTP) PATIENTS: COMPARISON OF TWO DIFFERENT METHODS
Bajwa R.S.	-	POTENTIAL ROLE OF ADAMTS13/FXI COMPLEXES IN THE PATHOGENESIS OF ESRD
	-	FIBRINOLYTIC DEFICIT CONTRIBUTES TO THE THROMBOTIC COMPLICATIONS IN END STAGE RENAL DISEASE. PROFILING OF PLASMINOGEN ACTIVATOR INHIBITOR, TISSUE PLASMINOGEN ACTIVATOR, FACTOR XIII THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR, AND ALPHA2 ANTIPLASMIN
Bajwa N.	-	INHIBITOR DEVELOPMENT IN PATIENTS WITH HEMOPHILIA A TREATED WITH SUCROSE-FORMULATED RECOMBINANT FACTOR VIII
Bajwa G.	-	UPREGULATION OF SURROGATE MARKERS OF INFLAMMATION AND THROMBOGENESIS IN ESRD PATIENTS, PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
Bajwa R.S.	-	HEMODIALYSIS DOWN REGULATES THE INFLAMMATORY MEDIATORS IN PATIENTS WITH END STAGE RENAL DISEASE
Bajzar L.	-	FIBRINOLYTIC CAPACITY OF CORD PLASMA COMPARED TO ADULT OVER VARIOUS CONCENTRATIONS OF TPA
Baker C.H.	-	IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION
Baker P.	-	COMPARISON OF AN IMMUNO-TURBIDOMETRIC D-DIMER METHOD WITH AN ESTABLISHED ENZYME-LINKED FLUORESCENT D-DIMER FOR THE EXCLUSION OF VENOUS THROMBOEMBOLISM
Baker R.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Baker A.H.	-	HEPATIC TARGETING OF ADENOVIRUS MEDIATED BY COAGULATION FACTOR X
Baker J.	-	INHIBITOR DEVELOPMENT IN SEVERE HEMOPHILIA A: IS THE RISK ASSOCIATED WITH PRODUCT TYPE?
Bakhos M.	-	DIFFERENTIAL EFFECTS OF FXA INHIBITORS AND HEPARINS IN SIMULATED ARTERIAL AND VENOUS THROMBOSIS
	-	EVALUATION OF ALLOSTERIC INHIBITORS OF PAR1 ON PLATELET ACTIVATION
	-	GENERIC VERSIONS OF BRANDED LOW MOLECULAR WEIGHT HEPARINS CAN BE DIFFERENTIATED IN BIOLOGIC AND PHARMACOLOGIC ASSAYS
	-	POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Bakker S.J.L.	-	CYTOMEGALOVIRUS AND HIGH RISK OF (RECURRENT) VENOUS THROMBOSIS AFTER RENAL TRANSPLANTATION
Bal dit Sollier C.	-	DIET MANIPULATION OF ATHEROSCLEROTIC LESIONS IN THE FHD PIG MODEL
	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
	-	D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION
	-	BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS
	-	RESISTANCE TO OAC ASSOCIATED TO A NEW POINT MUTATION IN VKORC1 GENE
	-	HCAN CHANGES IN HEMOSTATIC PARAMETERS EXPLAIN THE INCREASED INCIDENCE OF DVT IN ELDERLY ?
	-	CYP2C19*2 POLYMORPHISM INFLUENCES PLATELET FUNCTIONNALITY IN RESPONSE TO CLOPIDROGEL TREATMENT
	-	PROTEIN Z LEVEL AND GENE POLYMORPHISMS IN MYOCARDIAL INFARCTION IN THE YOUNG
	-	FUNCTIONAL VARIABILITY OF PLATELET RESPONSE TO CLOPIDOGREL CORRELATES WITH P2Y12 RECEPTOR OCCUPANCY
Balandina A.N.	-	THRESHOLD BEHAVIOR OF THE BLOOD CLOTTING SYSTEM ACTIVATED BY THE TISSUE FACTOR
Balasa V.V.	-	THROMBOPHILIC POLYMORPHISMS IN PEDIATRIC CATHETER RELATED VERSUS NON CATHETER RELATED VENOUS THROMBOEMBOLISM
	-	INCREASED AGE RELATED EXPRESSION OF FVIII IN TWO UNRELATED FEMALES WITH SEVERE HEMOPHILIA A AND NONRANDOM X-INACTIVATION
Balazic J.	-	T1-WEIGHTED MAGNETIC RESONANCE IMAGING DIFFERENTIATES PLATELETS IN PULMONARY EMBOLI EX VIVO
Baldan N.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Baldassarre D.	-	ASSOCIATION OF TISSUE FACTOR A-603G GENOTYPE WITH CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS IN CARDIOVASCULAR RISK PREVENTION
	-	E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY
Baldassarri S.	-	MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
	-	EFFECTS OF 8-PRENYLNARINGENIN, A NOVEL PHYTOESTROGEN, ON HUMAN PLATELETS
	-	DEHYDROEPIANDROSTERONE INHIBITS PLATELET AGGREGATION
Baldi G.	-	RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
Balducchi J.P.	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
Balducci D.	-	PROGNOSTIC SIGNIFICANCE FOR VENOUS THROMBOEMBOLISM (VTE) OF HEMOSTATIC MARKERS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE
	-	DIFFERENTIAL EFFECTS OF RETINOIDS ON THE PROCOAGULANT ACTIVITY (PCA) AND CYTO-DIFFERENTIATION OF LEUKEMIC CELLS FRESHLY ISOLATED FROM ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS
	-	ALL-TRANS RETINOIC ACID (ATRA) INHIBITS ENDOTHELIAL ANGIOGENESIS INDUCED BY TUMOR CELLS AND STANDARD FACTORS
	-	ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) DALTEPARIN REDUCES THE PROTHROMBOTIC AND PROANGIOGENIC POTENTIAL OF MICROVASCULAR ENDOTHELIAL CELLS ELICITED BY TUMOR CELLS
Balduini C.L.	-	GIANT PLATELET DISORDERS
	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Balduini C.	-	CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Balduini C.L.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Balduini A.	-	VON WILLEBRAND FACTOR AND GPIB-IX-V REGULATE PROPLATELETS FORMATION BY HUMAN MEGAKARYOCYTES
Balduini C.L.	-	VON WILLEBRAND FACTOR AND GPIB-IX-V REGULATE PROPLATELETS FORMATION BY HUMAN MEGAKARYOCYTES
Balduini C.	-	EVIDENCE FOR THROMBIN-INDUCED PLATELET ACTIVATION INDEPENDENT OF PAR1, PAR4, AND GPIB-IX-V
Balduini C.L.	-	MARKED EMPERIPOLESIS AND INCREASED P-SELECTIN EXPRESSION ON MEGAKARYOCYTES IN A NOVEL CASE OF GRAY PLATELET SYNDROME
Baldwin A.C.W.	-	CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
Balen S.	-	TREATMENT OF SURGICAL PATIENTS WITH FRESH FROZEN PLASMA AT THE CLINICAL HOSPITAL CENTER RIJEKA
Balkan C.	-	RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS
Ball S.	-	THE SIGNIFICANCE OF BREAKPOINT DELINEATION IN LARGE DELETIONS IN THE F8 GENE
Ball C.	-	SHEAR-INDUCED DISULFIDE BOND FORMATION REGULATES ADHESION ACTIVITY OF VON WILLEBRAND FACTOR
Ballal R.	-	ECONOMIC BENEFITS OF KNEE SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII IN HEMOPHILIA PATIENTS WITH INHIBITORS
Ballarino G.J.	-	CLINICAL AUDIT OF THROMBOEMBOLISM PROPHYLAXIS 3 YEARS AFTER THE 6TH ACCP REPORT IN A TERTIARY CARE HOSPITAL FROM CRDOBA, ARGENTINA
Ballarino P.	-	RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
Ballerio R.	-	BIOCHEMICAL AND MECHANICAL PROPERTIES OF INTRALUMINAL THROMBUS FROM HUMAN ABDOMINAL AORTIC ANEURYSM
Ballesteros I.	-	ACQUIRED HEMOPHILIA IN AN HIV PATIENT
Balliel W.M.R.	-	IN VIVO AVAILABILITY OF TWO RECOMBINANT FACTOR VIII PRODUCTS
	-	COMPARISON OF THROMBIN GENERATION AND FVIII LEVEL MEASUREMENTS IN HAEMOPHILIA PATIENTS AFTER RECOMBINANT FACTOR VIII TREATMENT
Balogh E.	-	MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
Balogh I.	-	ANALYSIS OF SURFACE AND SOLUBLE L-SELECTIN IN RELATION TO FLOW CYTOMETRIC PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Balogh E.	-	ELEVATED FACTOR XIII LEVEL IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION IN WOMEN
Balogh I.	-	GENERATION AND EXPRESSION OF RECOMBINANT FACTOR XIII-B MUTANTS
Balsemin F.	-	EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Baltasar F.	-	POTENTIAL ROLE OF ADAMTS13/FXI COMPLEXES IN THE PATHOGENESIS OF ESRD
Balthazor S.M.	-	RARE ANTIGENS IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Balvay D.	-	ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA?
Bandarenko N.	-	ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
	-	RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Bandel T.J.	-	LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
Bandinelli S.	-	HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY
	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
Bandinelli B.	-	ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
Banfi C.	-	PROTEOME OF ENDOTHELIAL CELL-DERIVED PROCOAGULANT MICROPARTICLES
	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
	-	TISSUE FACTOR INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 REQUIRES INTACT CAVEOLIN-ENRICHED MEMBRANE MICRODOMAINS IN HUMAN ENDOTHELIAL CELLS
Bang S.S.M.	-	CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Bang K.W.A.	-	INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN PHOSPHATIDYLSERINE-EXPOSING HUMAN PLATELETS IS INDEPENDENT OF CALPAIN ACTIVITY
Bang S.	-	FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
Bang K.W.A.	-	BERNARD-SOULIER PLATELETS EXPOSE MORE PROCOAGULANT PHOSPHATIDYLSERINE (PS), WITH PAR1 AND PAR4 MEDIATING THE SYNERGISTIC EFFECT OF THROMBIN ON COLLAGEN-STIMULATED PS EXPRESSION
Banik N.	-	RISK PROFILE OF PATIENTS WITH DVT DIAGNOSED IN AMBULATORY CARE - DATA FROM THE GERMAN TULIPA REGISTRY
Banno F.	-	THE DISTAL CARBOXYL-TERMINAL DOMAINS OF ADAMTS13 ARE REQUIRED IN VIVO FOR EFFICIENT CLEAVAGE OF VON WILLEBRAND FACTOR UNDER PROTHROMBOTIC CONDITIONS
Banno M.	-	GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Bansal V.	-	ANTIINFLAMMATORY EFFECTS OF ARGATROBAN CAN BE DIFFERENTIATED FROM OTHER DIRECT THROMBIN INHIBITORS. EXPERIMENTAL AND CLINICAL OBSERVATIONS
	-	POTENTIAL ROLE OF ADAMTS13/FXI COMPLEXES IN THE PATHOGENESIS OF ESRD
	-	UPREGULATION OF MYELOPEROXIDASE IN END STAGE RENAL DISEASE AND ITS MODULATION BY HEMODIALYSIS
	-	PREVALENCE OF CROSS-REACTIVE EPITOPES TO BOVINE FACTOR VA LIGHT CHAIN FRAGMENTS IN NORMALS AND END STAGE RENAL DISEASE PATEINTS
	-	FIBRINOLYTIC DEFICIT CONTRIBUTES TO THE THROMBOTIC COMPLICATIONS IN END STAGE RENAL DISEASE. PROFILING OF PLASMINOGEN ACTIVATOR INHIBITOR, TISSUE PLASMINOGEN ACTIVATOR, FACTOR XIII THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR, AND ALPHA2 ANTIPLASMIN
	-	HEMODIALYSIS DOWN REGULATES THE INFLAMMATORY MEDIATORS IN PATIENTS WITH END STAGE RENAL DISEASE
	-	UPREGULATION OF SURROGATE MARKERS OF INFLAMMATION AND THROMBOGENESIS IN ESRD PATIENTS, PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
Banu E.	-	PLATELET MICROPARTICLES ARE A PREDICTIVE FACTOR OF OVERALL SURVIVAL IN PATIENTS WITH PROSTATE CANCER
Banu A.	-	PLATELET MICROPARTICLES ARE A PREDICTIVE FACTOR OF OVERALL SURVIVAL IN PATIENTS WITH PROSTATE CANCER
Bao J.	-	CONSTRUCTION AND IDENTIFICATION OF LENTIVIRUS - MEDIATED RNAI VECTORS CONTAINING HUMAN TISSUE FACTOR
Baralle F.E.	-	PROTHROMBOTIC EFFECTS OF FIBRONECTIN ISOFORMS CONTAINING THE EDA DOMAIN
Baran B.	-	"IMPACT R" - A NEW SCREENING TOOL FOR VON WILLEBRAND DISEASE?
	-	THE EFFECT OF APCC AND PCC ON THE GENERATION OF THROMBIN IN HAEMOPHILIA A PATIENTS WITH FVIII INHIBITOR: A CROSS-OVER PHARMACOKINETIC STUDY
	-	WHAT DOES HIGH PREVALANCE OF FACTOR V LEIDEN MUTATION IN POLISH SEVERE HAEMOPHILIACS MEAN?
Barandier C.	-	HYPERACTIVE C-JUN N-TERMINAL KINASE ENHANCES VASCULAR TISSUE FACTOR EXPRESSION IN AGING
Baras Y.	-	THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS
Barash J.	-	THROMBOPHILIA DOES NOT INCREASE THE RISK FOR RECURRENT THROMBOSIS IN PEDIATRIC APS
Barban M.	-	BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
Barbatis C.	-	CD36 AND SRA GENE EXPRESSION IN HUMAN CAROTID ENDARTERECTOMY LESIONS
Barbeaux P.	-	THE HUMANIZED ANTI-GPIB MONOCLONAL ANTIBODY 6B4-FAB ABOLISHES THROMBUS FORMATION IN A MODIFIED FOLTS' MODEL IN BABOONS
Barbieri S.S.	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
	-	PARACRINE UP-REGULATION OF MONOCYTE CYCLOOXYGENASE-2 BY PLATELETS: ROLE OF TGF-BETA1
	-	TOBACCO SMOKE COOPERATES WITH INTERLEUKIN-1B TO ALTER B-CATENIN TRAFFICKING IN VASCULAR ENDOTHELIUM RESULTING IN INCREASED PERMEABILITY AND INDUCTION OF CYCLOOXYGENASE-2 EXPRESSION IN VITRO AND IN VIVO
	-	CYCLOOXYGENASE-2 IS CRITICAL FOR HYDROGEN PEROXIDE-MEDIATED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS
Barbui T.	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
	-	ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
	-	THROMBIN GENERATION IN CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
	-	PROGNOSTIC SIGNIFICANCE FOR VENOUS THROMBOEMBOLISM (VTE) OF HEMOSTATIC MARKERS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE
Barcella S.	-	TISSUE FACTOR INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 REQUIRES INTACT CAVEOLIN-ENRICHED MEMBRANE MICRODOMAINS IN HUMAN ENDOTHELIAL CELLS
	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
Barcellona D.	-	PERIODICAL LABORATORY EVALUATION OF PORTABLE COAGULOMETERS
	-	ANTIPHOSPHOLIPID SYNDROME AND PORTABLE COAGULOMETERS
Barcelona S.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Barchitta A.	-	SUBMASSIVE PULMONARY EMBOLISM: ROLE OF THROMBOLITIC THERAPY
Barco S.L.	-	EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
Bardan D.	-	IMPACT OF FVIII PRODUCT CHANGE IN SEVERE HAEMOPHILIA A PATIENTS PREVIOUSLY TREATED WITH PLASMA-DERIVED FVIII
Bare L.A.	-	FACTOR IX MALM IS ASSOCIATED WITH VENOUS THROMBOSIS
	-	GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
	-	A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS
Baretton G.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Barhoover M.A.	-	CONTRIBUTION OF ASP334 AND TYR335 OF FACTOR VA TO PROTHROMBINASE FUNCTION
	-	ALLOSTERIC REGULATION OF PROTHROMBIN ACTIVATION BY FACTOR VA
	-	THE ROLE OF THE ACIDIC COOH-TERMINAL REGION OF FACTOR VA HEAVY CHAIN DURING ACTIVATION OF PROTHROMBIN BY PROTHROMBINASE
Bari S.	-	EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET
	-	EFFECT OF NYTROXYL AND NITRIC OXIDE ON HUMAN PLATELET ARACHIDONATE METABOLISM
Barillari G.	-	PROTHROMBOTIC FACTORS IN INFANTS WITH NEONATAL CEREBRAL INFARCTION
	-	RECOMBINANT ACTIVATED FACTOR VII IN THE TREATMENT OF ACUTE POST PARTUM HEMORRHAGE: THE ITALIAN REGISTRY
	-	SAFETY AND EFFICACY OF NADROPARIN FOR THE MANAGEMENT OF VENOUS THROMBOEMBOLISM OR THROMBOPHILIA IN PREGNANCY
	-	PROTHROMBOTIC FACTORS AND OXIDATIVE STRESS MARKERS IN A TYPE 2 DIABETES POPULATION
	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
Barker K.	-	ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) EXPERIENCE ASSESSED THROUGH ONGOING POST-AUTHORIZATION SAFETY SURVEILLANCE (PASS)
Barnard J.	-	P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
Barnard M.R.	-	CYSTIC FIBROSIS HETEROZYGOTES DO NOT HAVE INCREASED PLATELET ACTIVATION
Barnett T.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
	-	PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS
	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Baron J.A.	-	VENOUS THROMBOEMBOLISM AND SUBSEQUENT HOSPITALIZATION DUE TO ACUTE CARDIOVASCULAR EVENTS. A 20 YEARS FOLLOW-UP STUDY
Baronciani L.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Barone M.	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
	-	LONG TERM RESULTS OF PULMONARY ENDARTERECTOMY (PEA) IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). THE PAVIA ENDARTERECTOMY PROGRAM
	-	EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
Baroni M.	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
	-	RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS
Barozzi L.	-	SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION
Barragan P.	-	VASP PHOSPHORYLATION ANALYSIS PRIOR TO PERCUTANEOUS CORONARY INTERVENTION FOR EXCLUSION OF POST-PROCEDURAL MAJOR ADVERSE CARDIOVASCULAR EVENTS
Barral F.G.	-	RETRIEVABLE VENA CAVA FILTERS FOR SECONDARY PREVENTION OF PULMONARY EMBOLISM IN ORTHOPAEDIC SURGERY
Barreiro E.J.	-	NEW THIENYLACYLHYDRAZONE DERIVATIVES AS CYCLIC NUCLEOTIDES MODULATORS AND PLATELET AGGREGATION INHIBITORS
Barrelier M.	-	A NOVEL P.ASP344VAL SUBSTITUTION IN THE FIBRINOGEN GAMMA-CHAIN CAUSES DYSFIBRINOGENEMIA ASSOCIATED WITH THROMBOSIS
Barrett J.	-	PHARMACOKINETICS AND DOSE-FINDING OF FRAGMIN IN PEDIATRIC PATIENTS AT RISK FOR THROMBOEMBOLIC EVENTS
Barrett N.E.	-	TACHYKININS AND THE NEUROKININ RECEPTOR 1 ARE REQUIRED FOR PLATELET THROMBUS FORMATION
Barrett Y.	-	APIXABAN, AN ORAL DIRECT FACTOR XA INHIBITOR: MULTIPLE-DOSE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
Barro C.	-	TAFI ACTIVITY LEVELS AND RECURRENT VENOUS THROMBOEMBOLIC DISEASE
	-	RISK FACTORS PREDICTIVE OF CARDIOVASCULAR EVENTS IN AN INCIDENT DIALYSIS COHORT: A ROLE FOR HOMOCYSTEINEMIA AND ITS MTHFR GENOTYPE
Barrow R.T.	-	FUNCTIONAL CHARACTERIZATION OF STRUCTURAL EPITOPES IN THE C2 DOMAIN OF FACTOR VIII
Barrowman N.J.	-	A COMPARISON OF ANTICOAGULANTS (AC) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS (PROPH) AFTER ORTHOPEDIC SURGERY (OS) USING A CLINICAL COST-EFFECTIVENESS ANALYSIS (CEA) APPROACH
Bartegi A.	-	RELEVANCE OF CA2+ ENTRY TO PLATELET AGGREGATION BY ACTIVATION OF THROMBIN RECEPTORS
Barth A.	-	THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM
Barthet M.C.	-	RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT
Bartholomew J.	-	NOVEL RISK FACTORS FOR DEEP VEIN THROMBOSIS IN HOSPITALIZED PATIENTS
Bartkova A.	-	TISSUE PLASMINOGEN ACTIVATOR, PLASMINOGEN ACTIVATOR INHIBITOR-1 AND VON WILLEBRAND FACTOR IN THE ACUTE AND CONVALESCENT PHASE OF ISCHEMIC STROKE
Bartle W.	-	INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR AT INR VALUES GREATER THAN 4
Bartmann P.	-	INFLUENCE OF PERINATAL RISK FACTORS ON THE DEVELOPMENT OF PLASMATIC COAGULATION IN EXTREMELY PRETERM INFANTS
Bartomioli M.	-	THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY
Bartosova L.	-	ACQUIRED HAEMOPHILIA A WITH INHIBITOR - CASE REPORT
	-	STICKY PLATELET SYNDROME (SPS) AND PLATELET GLYCOPROTEIN POLYMORPHISMS
Bartzeliotou A.	-	CIRCULATING LEVELS OF ADHESION MOLECULES AND MARKERS OF ENDOTHELIAL DYSFUNCTION IN ACUTE INFLAMMATION INDUCED BY PROLONGED BRISK EXERCISE: RAPID ENDOTHELIAL RECOVERY AND POTENTIAL BENEFICIAL EFFECTS
Baruch D.	-	DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE
Barz D.	-	THE VALUE OF ROTEM THROMBOLELASTOMETRY TO DETECT DISTURBED HAEMOSTASIS AND BLEEDING RISK IN ON-PUMP CARDIAC SURGERY
	-	EXCESS THROMBIN GENERATION IN PATIENTS AFTER ON-PUMP CARDIAC SURGERY
Basha S.	-	THROMBOPHILIA & RECURRENT FETAL LOSS: SHOULD WE SCREEN BOTH PARENTS ?
Bashash D.	-	HEREDITARY THROMBOPHILIC DEFECTS IN IRANIAN PATIENTS WITH CEREBRO VASCULAR ACCIDENT
	-	HEREDITARY DEFICIENCIES OF ANTITHROMBIN, PROTEIN S, AND THE PROTEIN C PATHWAY IN IRANIAN DVT PATIENTS
Basile A.M.	-	INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE
Basili S.	-	OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM
	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
	-	DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
	-	ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA
Basire A.	-	ENDOTHELIAL MARKERS OF INJURY/REPAIR EQUILIBRIUM IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
Baskova I.P.	-	NORMALIZATION OF ENDOTHELIUM FUNCTIONS AS A RESULT OF HIRUDOTHRAPY
Baslar Z.	-	EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
	-	FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES
Basnec Brkic A.	-	INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS
Bassand J.	-	FONDAPARINUX IS SAFER THAN ENOXAPARIN IN ELDERLY PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES: A SUBANALYSIS OF OASIS-5
	-	EARLY SAFETY BENEFIT OF FONDAPARINUX VERSUS ENOXAPARIN IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES: A SECONDARY ANALYSIS OF THE OASIS-5 TRIAL
Bassitt R.P.	-	DIFFICULTIES IN THE TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA WITH BLEEDING SYMPTOMS
	-	MUNCHAUSEN SYNDROME X COAGULOPATHIES
	-	ACUTE THROMBOSIS IN A PATIENT WITH ACQUIRED FVIII INHIBITOR: CASE REPORT
Bassler N.	-	CONFORMATION-SPECIFIC BLOCKADE OF THE INTEGRIN GPIIB/IIIA): IN VITRO AND IN VIVO RESULTS DEMONSTRATING A SELECTIVE PLATELET BLOCKADE WITH LESS ADVERSE EFFECTS
	-	A NOVEL SINGLE-CHAIN (SCFV) ANTIBODY PHAGE-DISPLAY STRATEGY FOR THE DEVELOPMENT OF POTENTIAL ANTI-ATHEROSCLEROTIC DRUGS
	-	MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
	-	EVIDENCE FOR AN ALTERNATIVE REGULATION OF THE ACTIVITY OF THE BETA3-INTEGRIN ALPHAVBETA3 IN THE ABSENCE OF THE HIGHLY CONSERVED ALPHA-SUBUNIT GFFKR MOTIF
Bastard C.	-	MONOCYTE PARAMETERS TO DISCRIMINATE ESSENTIAL FROM REACTIVE THROMBOCYTOSIS
Bastos L.A.	-	ANTITHROMBIN (AT): A CONFORMATIONAL VARIANT?
	-	DIAGNOSIS AND FOLLOW UP OF FACTOR XIII DEFICIENCY: COMPARISON OF DIFFERENT CLOT-SOLUBILITY TESTS
Basuyau J.	-	MONOCYTE PARAMETERS TO DISCRIMINATE ESSENTIAL FROM REACTIVE THROMBOCYTOSIS
Bataneant M.	-	HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
Batar B.	-	DNA REPAIR GENE XRCC1 AND XPD POLYMORPHISMS AND THEIR ASSOCIATION WITH CORONARY ARTERY DISEASE RISKS AND MICRONUCLEUS FREQUENCY
Batayeva E.P.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Bates S.M.	-	ACCURACY AND USEFULNESS OF A CLINICAL PREDICTION RULE AND D-DIMER TESTING IN EXCLUDING DEEP VEIN THROMBOSIS (DVT) IN CANCER PATIENTS
	-	RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
	-	A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Batista I.F.C.	-	AMBLYOMIN-X IN CULTURED CANCER CELLS: CITOTOXICITY AND CELL CYCLE EFFECTS
Batista J.F.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Batlle J.	-	"PRIMARY" PROPHYLACTIC TREATMENT WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) DURING INMUNE TOLERANCE IN A HAEMOPHILIC CHILD
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Batlle Fonrodona J.	-	RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN THE TREATMENT OF CRITICAL HAEMORRHAGE. A SINGLE CENTRE EXPERIENCE
Batorova A.	-	BLEEDING AND THROMBOTIC MANIFESTATION IN 58 PATIENTS WITH CONGENITAL DYSFIBRINOGENEMIA
	-	INHIBITOR OF FVII IN CONGENITAL SEVERE FACTOR VII DEFICIENCY
	-	GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY
	-	FACTOR VIIII INHIBITOR IN SEVERE HEMOPHILIA A TREATED WITH PD-FVIII CONCENTRATES
	-	TORPID CLINICAL COURSE OF THROMBOTIC THROMBOCYTOPENIC PURPURA
Battaglioli T.	-	THE ENDOGENOUS THROMBIN POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM
	-	THE RISK OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN DOUBLE CARRIERS OF FACTOR V LEIDEN AND PROTHROMBIN G20210A
	-	A RANDOMIZED, CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF LMWH ON PREGNANCY OUTCOME OF WOMEN WITH PREVIOUS PREGNANCY COMPLICATIONS. H.A.P.P.Y. STUDY
Battiston M.	-	ALTERED BINDING OF PURIFIED TYPE 2M VICENZA VON WILLEBRAND FACTOR TO PLATELET RECEPTOR ALPHAIIBBETA3 AND GPIB-V-IX COMPLEX
	-	SPATIO-TEMPORAL CALCIUM SIGNALING ELICITED BY INTEGRIN ALPHA2-BETA1 AND GLICOPROTEIN VI UNDER FLOW
Battle J.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
Baudin B.	-	DIET MANIPULATION OF ATHEROSCLEROTIC LESIONS IN THE FHD PIG MODEL
Baudo F.	-	FALSE UNCOAGULABLE PT-INR RESULTS
Bauduer F.	-	TWO APPARENT MISSENSE MUTATIONS IN EXONS OF THE FACTOR XI GENE CAUSE SPLICING DEFECTS DISPLAYING A NOVEL MECHANISM FOR MUTATIONS IN CLOTTING FACTORS
	-	IS PROTEIN S (PS) DEFICIENCY RARER IN THE BASQUES ?
Bauer M.	-	EXPRESSION AND SECRETION OF ADAMTS13 IS INHIBITED BY PROINFLAMMATORY STIMULATION
Bauer S.	-	DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS
Bauer M.	-	BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY
Bauer K.	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
Bauersachs J.	-	HIGH INCIDENCE OF CLOPIDOGREL NON-RESPONSIVENESS IN PATIENTS WITH CORONARY ARTERY DISEASE A REAL WORLD SITUATION
	-	THE CHEMOKINE FRACTALKINE MEDIATES LEUKOCYTE RECRUITMENT TO INFLAMMATORY ENDOTHELIUM AT ARTERIAL SHEAR RATES IN VIVO AND IN VITRO
Bauersachs R.	-	RISK PROFILE OF PATIENTS WITH DVT DIAGNOSED IN AMBULATORY CARE - DATA FROM THE GERMAN TULIPA REGISTRY
Bauersachs J.	-	INCREASED EXPRESSION OF AND ENHANCED PLATELET REACTIVITY TO FRACTALKINE IN TYPE-II DIABETIC ZDF-RATS
Bauersachs R.	-	DIAGNOSTIC WORK-UP AND DIAGNOSTIC SAFETY IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS DATA FROM THE GERMAN TULIPA REGISTRY
Bauersfeld U.	-	SELF-CONTROL OF ORAL ANTICOAGULATION USING A PORTABLE PROTHROMBIN TIME MONITOR IN PAEDIATRIC CARDIAC PATIENTS
Bauman M.E.	-	KNOWLEDGE RETENTION IMPROVES OUTCOMES FOR CHILDREN REQUIRING VITAMIN K ANTAGONISTS
	-	ACCURACY OF THE COAGUCHEK XS FOR POC INR IN CHILDREN REQUIRING WARFARIN
	-	POINT OF CARE INR MONITORING IN CHILDREN WITH VENTRICULAR ASSIST DEVICES
Bauman M.	-	DOES INCREASING THE STARTING DOSE OF ENOXAPARIN RESULT IN BETTER TREATMENT OF CHILDREN REQUIRING THROMBOPROPHYLAXIS? A RETROSPECTIVE COHORT STUDY
Bauman M.E.	-	KIDCLOT: KIDS INFORMED DECREASE COMPLICATIONS; LEARNING ON THROMBOSIS-CHILD FOCUSED EDUCATION TO FACILITATE ADHERENCE
	-	KIDCLOT: KIDS INFORMED DECREASE COMPLICATIONS; LEARNING ON THROMBOSIS-CHILD FOCUSED EDUCATION TO FACILITATE ADHERENCE
Baumbach G.	-	A PHASE I TRIAL OF LOCALLY-DELIVERED HUMAN PLASMIN TO EVALUATE SAFETY AND THROMBOLYTIC EFFICACY IN PATIENTS WITH HEMODIALYSIS GRAFT OCCLUSION (HGO)
Baumeister W.	-	VISUAL APPROACH TO PROTEOMICS
Baumgartner B.	-	PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD
	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
	-	PRIMARY HEMOSTATIC EFFICACY OF RVWF IN A NOVEL MODEL OF VASCULAR INJURY IN MICE WITH SEVERE VWF DEFICIENCY
Bauters A.	-	ROTEM THROMBOELASTOMETRY IN OBSTETRIC: NEAR PATIENT-TEST AS AN EARLY PREDICTOR OF POST-PARTUM HEMORRHAGE (PPH)
	-	ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
Bauvois B.	-	THIOSULFINATES MODULATE PLATELET ACTIVATION AND MONOCYTE FUNCTION BY REACTION WITH SURFACE FREE SULFHYDRYLS AND INTERNAL THIOL-CONTAINING PROTEINS
Bay J.O.	-	SECONDARY PROPHYLAXIS WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A SEVERE HAEMOPHILIA A PATIENT WITH ANTI-FACTOR VIII INHIBITORS
Bayer R.J.	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
	-	DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
Bayer A.	-	STERILIZATION OF PLATELET CONCENTRATES BY IRRADIATION WITH SHORT-WAVE ULTRAVIOLET LIGHT
Bayry J.	-	EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES
	-	IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS
Bazzan M.	-	ANTIPHOSPHOLIPID ANTIBODY TESTING IN PIEMONTE AND VALLE D'AOSTA: A MULTILABORATORY EXTERNAL QUALITY ASSURANCE (EQA) PROGRAM
Beam D.M.	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Beaudin S.	-	EFFECTS OF CHEMOTHERAPY AGENTS ON ENDOTHELIAL AND MONOCYTE HEMOSTASIS
	-	NOVEL REGULATORY FUNCTIONS OF ACTIVATED PROTEIN C: UPREGULATION OF INTERLEUKIN-10 AND INHIBITION OF TISSUE FACTOR IN BLOOD MONOCYTES
Beaufils P.	-	D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION
Beaufort C.	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
Beaulieu L.M.	-	SERPINS IN THROMBOSIS, HEMOSTASIS AND FIBRINOLYSIS
	-	ACTIVATED PROTEIN C HAS BOTH INTRACELLULAR AND EXTRACELLULAR EFFECTS ON BREAST CANCER AND ENDOTHELIAL CELL MIGRATION
Beavis J.	-	COMPARISON OF AN IMMUNO-TURBIDOMETRIC D-DIMER METHOD WITH AN ESTABLISHED ENZYME-LINKED FLUORESCENT D-DIMER FOR THE EXCLUSION OF VENOUS THROMBOEMBOLISM
Becattini C.	-	HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
	-	PROGNOSTIC VALUE OF TROPONINS IN ACUTE PULMONARY EMBOLISM: A META-ANALYSIS
	-	PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION
	-	CARDIOVASCULAR RISK FACTORS AND VENOUS THROMBOEMBOLISM: A META-ANALYSIS
	-	EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Bechyne I.	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
Beck D.O.	-	CONTRIBUTION OF ASP334 AND TYR335 OF FACTOR VA TO PROTHROMBINASE FUNCTION
Beck R.	-	FLOVAGATRAN (TGN 255), BIVALIRUDIN AND MELAGATRAN - DIFFERENTIAL PHARMACOLOGICAL EFFECTS ON THROMBIN GENERATION
Beck D.O.	-	IDENTIFICATION OF A BINDING SITE FOR FACTOR XA ON THE LIGHT CHAIN OF FACTOR VA
Becka M.	-	EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR
	-	THE EFFECT OF AGE AND GENDER ON THE PHARMACOLOGY AND SAFETY OF THE ORAL, DIRECT FACTOR XA INHIBITOR RIVAROXABAN
	-	RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR HAS NO CLINICALLY RELEVANT INTERACTION WITH ACETYLSALICYLIC ACID OR NAPROXEN
Becker R.C.	-	DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
Becker K.	-	POTENTIAL USE OF LIGANDS TO FVIII INHIBITORS
Becker P.	-	FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
Becker R.C.	-	PLATELET AGGREGATION AND SEROTONIN ACTIVITY
Beckers M.	-	THE VALUE OF PET- SCANNING IN THE DETECTION OF OCCULT CANCER IN PATIENTS WITH VENOUS THROMBOEMBOLISM
	-	IL 1A 899C/T AND IL4 589C/T ARE ASSOCIATED WITH VENOUS THROMBOEMBOLISM
Beckman M.	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: THROMBOPHILIA SCREENING IN CHILDREN
	-	ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN THE THROMBOPHILIA PILOT PROJECT
	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: MATERNAL THROMBOPHILIA
Beck-Peccoz P.	-	INSULIN-DEPENDENT CHANGES IN PAI-1 AND T-PA LEVELS AFTER A 6-MO TREATMENT WITH R-HGH IN GROWTH HORMONE DEFICIENT (GHD) ADULTS
Becquemont L.	-	VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY
Becquet D.	-	DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION
Bedell B.	-	A CALCIUM-DEPENDENT PROTEASE CLEAVES VWF73 AT THE PEPTIDE BOND CORRESPONDING TO V1607-T1608 IN THE A2 DOMAIN
Bedencic M.	-	VENOUS THROMBOEMBOLISM ASSOCIATED POLYMORPHISMS IN SLOVENE POPULATION
Bediz C.	-	THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Bednarek R.	-	KU80 AS A NOVEL RECEPTOR FOR THYMOSIN BETA4 THAT MEDIATES ITS INTRACELLULAR ACTIVITY DIFFERENT FROM G ACTIN SEQUESTERING
Beer J.H.	-	PERSISTENT PLATELET MICROPARTICLE FORMATION IN THE PRESENCE OF BLOCKERS OF GP IBALPHA, GPIIB/IIIA, CALCIUM CHELATORS AND ADP SCAVENGERS UNDER HIGH SHEAR STRESS
Beevers E.M.	-	HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
Begoña Criado M.	-	ROLE OF PLATELET GLYCOPROTEIN IB-ALPHA POLYMORPHISM IN PLATELET REACTIVITY
Begtrup K.	-	LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL
Béguin S.	-	THROMBIN GENERATING CAPACITY IS HIGHLY DECREASED AND DELAYED IN PATIENTS WITH VON WILLEBRAND DISEASE
Behar C.	-	INHERITED FVII DEFICIENCY MOLECULAR DIAGNOSIS: SCREENING FOR LARGE REARRANGEMENTS IN THE FVII GENE
Beharry N.	-	ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS
Behbehani R.	-	EVALUATION OF THE USE OF RECOMBINANT FVIIA, NOVOSEVEN IN 28 GLANZMANN'S THROMBASTHENIA PATIENTS
Beheiri A.	-	ROLE OF ELEVATED ALPHA2-MACROGLOBULIN REVISITED: RESULTS OF A CASE-CONTROL STUDY IN CHILDREN WITH SYMPTOMATIC THROMBOEMBOLISM
Bein G.	-	SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY LOW-AVIDITY ANTI-HPA-1A ALLOANTIBODIES
Bejrachandra S.	-	ACCURATE BEDSIDE DIAGNOSTIC KIT FOR DETERMINING HEMOPHILIA A AND
Beker B.D.	-	RECOMBINANT FVIIA USE IN THREE PRETERM NEONATES WITH DISSEMINATED INTRAVASCULAR COAGULATION
Bekers O.	-	MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
Beletic A.	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Belik J.	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX NEUTRALIZES PROCOAGULANT ACTIVITY INDUCED BY VENTILATION IN NEWBORNS
Bellan A.	-	DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION
Bellest L.	-	A NEW MODE OF PROTHROMBIN TIME (PT) REPORTING SPECIFIC FOR LIVER DISEASES
Belletrutti M.	-	DOES INCREASING THE STARTING DOSE OF ENOXAPARIN RESULT IN BETTER TREATMENT OF CHILDREN REQUIRING THROMBOPROPHYLAXIS? A RETROSPECTIVE COHORT STUDY
Belli S.	-	4G/5G POLYMORPHISM IN THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OBESE HISPANIC ADULTS
Bellido-Martin L.	-	INK4A/ARF DEFICIENT MICE HAVE A DEFICIENT PLATELET FUNCTION
Bellini T.	-	CHARACTERIZATION OF PAR-MEDIATED SIGNALING CAPACITY OF COAGULATION FACTOR X MUTANTS
Bello I.F.	-	ORTHOPAEDIC SURGERY IN TWO HAEMOPHILIC PATIENTS WITH HIGH-RESPONSE INHIBITORS
	-	NEW THERAPEUTIC APPROACH IN ACQUIRED HEMOFILIA
	-	PROPHYLAXIS WITH RECOMBINANT FVIIA
	-	SEVERE FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A PROTOCOL FOR LABOUR MANAGEMENT WITH FACTOR XI CONCENTRATE
	-	PRIMARY PROPHYLAXIS WITH RECOMBINANT FACTOR VIIA IN A PATIENT WITH HAEMOPHILIA A AND INHIBITOR
Bellosillo B.	-	INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
Bellosta S.	-	ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
Bellucci S.A.	-	HETEROGENEITY OF ESSENTIAL THROMBOCYTHEMIA: VARIABLE EXPRESSION OF THE V617F JAK2 MUTATION AND THE PLATELET CD36 LEVEL. NO ASSOCIATION WITH THROMBOTIC MANIFESTATIONS
Bellucci S.	-	CYP2C19*2 POLYMORPHISM INFLUENCES PLATELET FUNCTIONNALITY IN RESPONSE TO CLOPIDROGEL TREATMENT
	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Belluci S.	-	BIOLOGICAL INHIBITION OF PLATELET PROSTAGLANDIN PATHWAY IS NOT MAINTAINED BY LOW DOSE ASPIRIN THROUGHOUT 24 HOURS IN TYPE 2 DIABETIC PATIENTS
Beltrame M.P.	-	ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V
Beltrametti C.	-	EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
	-	LONG TERM RESULTS OF PULMONARY ENDARTERECTOMY (PEA) IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). THE PAVIA ENDARTERECTOMY PROGRAM
	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
Beltran C.	-	NATIONAL STUDY OF INHIBITOR KINETICS AND TREATMENT RESPONSE IN HEMOPHILIA A AND B MEXICAN PATIENTS
Belvini D.	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
	-	PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION
Belzunce M.	-	CYTOKINE-INDUCED MONOCYTE-ENDOTHELIAL CELL INTERACTIONS: EFFECT ON PAI-1 LEVELS
Ben Romdhane N.	-	ASSOCIATION OF HYPERHOMOCYSTEINEMIA WITH RESTENOSIS
	-	THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Benabadji C.S.	-	SEVERE HYPOFIBRINOGENEMIA ASSOCIATED WITH MIDDLE CEREBRAL ARTERIAL THROMBOSIS
Ben-amor N.	-	RELEVANCE OF CA2+ ENTRY TO PLATELET AGGREGATION BY ACTIVATION OF THROMBIN RECEPTORS
Benard S.	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Benattar N.	-	THE IMPORTANCE OF TYPE OF QUALITY CONTROL WHEN CHANGING REAGENT BATCHES
Bencur P.	-	ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE)
Bender M.	-	COFILIN, BUT NOT ADF, IS ESSENTIAL IN PLATELET FORMATION IN VIVO
Bender H.G.	-	RISK DETERMINANTS OF ARTERIAL THROMBOSIS INCREASE THE RISK OF INTRAUTERINE GROWTH RESTRICTION (IGR)
Bender M.	-	UNALTERED CA2+ HOMEOSTASIS AND AGONIST-INDUCED ACTIVATION IN PLATELETS LACKING TRANSIENT RECEPTOR POTENTIAL (TRP) C1
Bendszus M.	-	INHIBITION OF GPIB, BUT NOT GPIIB/IIIA, IMPROVES EXPERIMENTAL STROKE OUTCOME WITHOUT BLEEDING COMPLICATIONS
Benedik Dolni[ccaron]ar M.	-	INHIBITOR DEVELOPMENT IN 3 PATIENTS WITH HEMOPHILIA A AFTER INTENSIVE EXPOSURE TO FVIII CONCENTRATES BY CONTINUOUS INFUSION DATA FROM SLOVENIA
Benegas M.	-	CLINICAL AUDIT OF THROMBOEMBOLISM PROPHYLAXIS 3 YEARS AFTER THE 6TH ACCP REPORT IN A TERTIARY CARE HOSPITAL FROM CRDOBA, ARGENTINA
Beneke H.	-	MANAGEMENT OF SEVERE PULMONARY EMBOLISM IN A PATIENT WITH HOMOZYGOUS PROTEIN C DEFICIENCY
Benetos A.	-	AGE-DEPENDENT INCREASED ARTERIAL STIFFNESS IS ASSOCIATED WITH COMPOSITE CHANGES IN PRO- AND ANTI-COAGULANT REACTIONS IN SUBCLINICAL ATHEROSCLEROSIS
Benetucci J.	-	THROMBOPHILIA IN HIV-INFECTED PATIENTS WITH OSTEONECROSIS: IS THERE A REAL CONNECTION? THE FIRST CASE-CONTROL STUDY
Benford K.	-	THE PREVALENCE OF SYMPTOMATIC VON WILLEBRAND DISEASE (VWD) IN PRIMARY CARE PRACTICE
Bengler C.	-	PROSPECTIVE EVALUATION OF A SIMPLIFIED SCORE FOR THE PREDICTION OF DISSEMINATED INTRAVASCULAR COAGULATION IN SEPSIS
	-	SIMPLE COAGULATION TESTS IMPROVE EARLY MORTALITY PREDICTION IN ICU PATIENTS WITH SEPTIC SHOCK
Bengtsson T.	-	THE PERIODONTAL PATHOGEN PORPHYROMONAS GINGIVALIS INDUCES BLOOD COAGULATION THROUGH ACTIVATION OF FACTOR XI BY GINGIPAIN R
Benhadda B.	-	CLINICAL AND BIOLOGICAL ASPECTS OF VON WILLEBRAND DISEASE IN ALGERIA
Benhamou Y.	-	RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT
Ben-Hasan M.	-	CHARACTERISATION OF ASE-LIKE ELEMENTS IN THE HUMAN PROTEIN Z GENE PROMOTER
Benjamin S.	-	SOUTH EAST ENGLAND THROMBOTIC THROMBOCYTOPENIC PURPURA REGISTRY
	-	TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA WITH MABTHERA (RITUXIMAB)
Benjaponpitak S.	-	THE USE OF RITUXIMAB AS AN ADJUVANT THERAPY TO INDUCE IMMUNE TOLERANCE IN CHILDREN WITH HEMOPHILIA A AND B
Benlloch I.	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) GENE POLYMORPHISM AND RISK FOR VENOUS THROMBOSIS DISEASE (VTD)
Bennett M.	-	MEASURES OF THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS (CPB) IN
Bennett C.L.	-	ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
	-	RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Benson J.	-	VENOUS THROMBOEMBOLISM, FACTOR V LEIDEN, AND PROTHROMBIN 20210 AMONG AMERICAN CAUCASIANS IN THE GATE STUDY
Benson G.M.	-	THE USE OF THE WARKENTIN ET AL 4T CLINICAL SCORING SYSTEM TO DETERMINE PROSPECTIVELY THE APPROPRIATENESS OF HIT ANTIBODY TESTING AT THE REGIONAL HAEMOSTASIS LABORATORY, BELFAST CITY HOSPITAL, N IRELAND
Benzakour O.	-	EXPRESSION PATTERN OF PROTEIN S AND GAS6 IN THE RETINA
Beranek M.M.B.	-	FREQUENCY OF F II20210A IN WOMEN WITH VENOUS THROMBOEMBOLISM IN ASSOCIATION WITH ORAL CONTRACEPTIVE USE
Berard F.	-	IMMUNE RESPONSE AFTER FIRST AND SECOND IV INJECTION OF AVIDIN USED AS THE NEUTRALIZING AGENT FOR BIOTINYLATED IDRAPARINUX
Berber E.	-	INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
Berchio A.	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
Berchtold-Herz M.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
Berckmans R.J.	-	MICROPARTICLES DURING THE COURSE OF PAINFUL CRISES IN SICKLE CELL DISEASE
	-	ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V
Berda-Haddad Y.	-	SHORT-TERM OPTIMIZATION OF GLYCEMIC CONTROL WITH INTENSIVE INSULIN THERAPY DECREASE CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES LEVELS IN TYPE 2 DIABETIC PATIENTS
Berdel W.E.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Bereczky Z.	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION TREATMENT OF THERAPY-RESISTENT ACQUIRED HAEMOPHILIA WITH HIGH INHIBITOR TITER: A CASE REPORT
	-	FACTOR XIII VAL34LEU VARIANT PROTECTS AGAINST CORONARY ARTERY DISEASE: A META-ANALYSIS
	-	COULD HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS BE A RARE MANIFESTATION OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME?
	-	ELEVATED FACTOR XIII LEVEL IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION IN WOMEN
	-	TWO NOVEL MISSENSE MUTATIONS (THR233MET AND TRP308LEU) IN THE FACTOR X GENE AND THEIR FUNCTIONAL CONSEQUENCES IN A PATIENT WITH SEVERE FACTOR X DEFICIENCY
	-	MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
Berent R.	-	PLATELET RESPONSE DOES NOT CHANGE DURING LONG-TERM-TREATMENT (8YEARS) WITH 50 OR 100 MG ACETYLSALICYLIC ACID (ASA) FOR SECONDARY PREVENTION
Beres B.J.	-	STUDY OF IN VIVO AND IN VITRO ADMINISTERED ASPIRIN'S ANTIPLATELET EFFECT: POSSIBLE MECHANISMS OF ASPIRIN RESISTANCE
Béres B.J.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Beres B.	-	ASSESSMENT OF PLATELET P2Y1 FUNCTION IN CLOPIDOGREL-TREATED ISCHEMIC HEART DISEASE PATIENTS
Beres B.J.	-	CLOPIDOGREL TREATMENT SIGNIFICANTLY DECREASES CIRCULATING ENDOTHELIAL CELL COUNT IN PATIENTS WITH STABLE ANGINA
Berg R.	-	THE USE OF FEIBA DURING SURGERIES IN HAEMOPHILIA PATIENTS WITH INHIBITORS TO FACTOR VIII AND IX
Bergamelli L.	-	MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
Berge N.	-	FUNCTIONAL VARIABILITY OF PLATELET RESPONSE TO CLOPIDOGREL CORRELATES WITH P2Y12 RECEPTOR OCCUPANCY
	-	BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS
	-	DIET MANIPULATION OF ATHEROSCLEROTIC LESIONS IN THE FHD PIG MODEL
Berger M.	-	ASSOCIATION OF ADAMDEC1 HAPLOTYPE WITH HIGH FACTOR VIII LEVELS IN VENOUS THROMBOEMBOLISM
Berger F.H.	-	PREVENTION OF TRAVELLERS' THROMBOSIS: A COMPARISON OF THREE INTERVENTIONS THAT PROMOTE VENOUS OUTFLOW
Berger J.S.	-	PLATELET AGGREGATION AND SEROTONIN ACTIVITY
Berger C.	-	HIGH DOSES OF RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A HEMOPHILIA A PATIENT WITH INHIBITOR
Bergeron A.	-	MEASURING MICROPARTICLES: PITFALLS AND MODIFICATIONS
	-	PURIFIED A2 DOMAIN OF VWF BINDS TO THE ACTIVE CONFORMATION OF VWF AND BLOCKS THE INTERACTION WITH PLATELET GPIB; A NOVEL A2 DOMAIN-DERIVED PEPTIDE INHIBITS VWF-GPIB INTERACTION UNDER HIGH FLOW CONDITIONS
Bergmann F.	-	CLINICAL EXPERIANCE WITH A RAPID SCREENING TEST FOR HEPARIN/PF4-ANTIBODIES
Bergmann J.F.	-	LATE BREAKING CLINICAL TRIAL: A LARGE-SCALE, GLOBAL OBSERVATIONAL STUDY OF VENOUS THROMBOEMBOLISM RISK AND PROPHYLAXIS IN THE ACUTE HOSPITAL CARE SETTING: THE ENDORSE STUDY
Bergmann J.	-	D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION
	-	HCAN CHANGES IN HEMOSTATIC PARAMETERS EXPLAIN THE INCREASED INCIDENCE OF DVT IN ELDERLY ?
Bergmeier W.	-	CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
Bergs S.	-	INFLUENCE OF HERITABILITY AND HOUSEHOLD COMPONENTS ON LIPID CONCENTRATIONS AND CLOTTING FACTOR LEVELS IN 282 PEDIATRIC STROKE FAMILIES
Bergstraesser E.	-	PORT--CATH-RELATED THROMBOSIS AND POSTTHROMBOTIC SYNDROME IN PAEDIATRIC ONCOLOGY PATIENTS: THE PACTOP STUDY
Berkes E.	-	STUDY OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM IN HELLP SYNDROME PATIENTS
	-	THE OCCURRENCE OF FACTOR V LEIDEN MUTATION IN HUNGARIAN HELLP SYNDROME PATIENTS
Berkun Y.	-	THROMBOPHILIA DOES NOT INCREASE THE RISK FOR RECURRENT THROMBOSIS IN PEDIATRIC APS
Berland Y.	-	THE UREMIC SOLUTE INDOXYL SULFATE INDUCES OXIDATIVE STRESS IN ENDOTHELIAL CELLS
Berlanga O.	-	COLLAGEN PROMOTES SUSTAINED GPVI SIGNALING IN PLATELETS AND CELL LINES
Bermeja E.	-	HETEROGENEITY WITHIN THE PROTEIN CONTENT OF SECRETORY ORGANELLES OF HUMAN PLATELETS
Bermejo E.	-	EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET
	-	EFFECT OF NYTROXYL AND NITRIC OXIDE ON HUMAN PLATELET ARACHIDONATE METABOLISM
Bermejo N.	-	LONG TERM ANTICOAGULATION WITH FONDAPARINUX FOR DIALYSIS DEPENDENT PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Bermudez M.C.	-	COMPARATIVE "IN VITRO" CHARACTERIZATION OF DIFFERENT PROTHROMBIN COMPLEX CONCENTRATES
Bernard A.	-	PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
	-	THE EFFECT OF APHERESIS ON DONORS' PLATELETS
	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
	-	INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
Bernard O.	-	ASSESSMENT OF THE PREDICTIVE VALUE OF PFA-100 TM OCCLUSION TIME CONCERNING THE HAEMORRHAGIC RISK OF TRANSPARIETAL NEEDLE LIVER BIOPSY IN CHILDREN
Bernardi F.	-	CHARACTERIZATION OF PAR-MEDIATED SIGNALING CAPACITY OF COAGULATION FACTOR X MUTANTS
Bernardi E.	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
Bernardi F.	-	INTRACELLULAR EVALUATION OF ER TARGETING ELUCIDATES A MILD FORM OF INHERITED COAGULATION DEFICIENCY
Bernardi E.	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
	-	BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
Bernardi M.E.	-	COMPARATIVE "IN VITRO" CHARACTERIZATION OF DIFFERENT PROTHROMBIN COMPLEX CONCENTRATES
Bernardi F.	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
	-	VITAMIN K-INDUCED VARIATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY
Bernardi M.	-	HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
Bernardi E.	-	COMPARISON OF FOUR CLINICAL PREDICTION MODELS IN PATIENTS WITH SUSPECTED PULMONARY EMBOLISM
Bernardi F.	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
	-	GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY
	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
Bernardi E.	-	GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT)
Bernardi F.	-	COAGULATION FACTOR XI LEVELS AND THE LDL RECEPTOR-RELATED PROTEIN (LRP) GENOTYPE
Bernardi E.	-	OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY
Bernardi F.	-	COAGULATION FACTOR VII LEVELS ARE MODULATED BY THE BIOLOGICAL CLOCK
	-	RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS
Bernasconi A.	-	LOW MOLECULAR THIOLS, PRO-COAGULANT STATE AND NATURAL ANTIOXIDANT SYSTEM IN HEMODIALYSIS PATIENTS
Berndt M.C.	-	CONTROL SHEDDING OF GPIB-IX-V AND GPVI BY ADAM FAMILY METALLOPROTEINASES
	-	A NOVEL ROLE FOR CADHERIN 6 IN PLATELET FUNCTION
	-	A ROLE FOR GEMS IN PLATELET GLYCOPROTEIN IB-MEDIATED PLATELET ACTIVATION
	-	RAPID LIGAND-INDUCED DIMERIZATION OF PLATELET GLYCOPROTEIN VI
	-	PROGRAMMED AUTOLOGOUS CLEAVAGE OF PLATELET RECEPTORS
Bernhardt F.	-	NOX4 IS STRONGLY INVOLVED IN ENDOTHELIAL PAI-1 SYNTHESIS
Bernstein J.	-	SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE
	-	VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS
Berntorp E.	-	ASSOCIATION BETWEEN A HISTORY OF INHIBITORS AND DELAYS IN SKELETAL MATURATION IN ADOLESCENTS WITH HEMOPHILIA
	-	THE CAPACITY TO GENERATE THROMBIN IN FACTOR VIII INHIBITOR PLASMAS DIFFERS AMONG COMMERCIAL CONCENTRATES AND IS ASSOCIATED WITH VON WILLEBRAND FACTOR CONTENT. IS THIS OF IMPORTANCE FOR ITI SUCCESS?
	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
	-	ESTROGEN TREATMENT OF CONSTITUTIONAL TALL STATURE IN GIRLS: RISK OF THROMBOSIS OR BLEEDING?
Berny M.A.	-	GLYCOPROTEIN Ib MEDIATES PLATELET RECRUITMENT, ACTIVATION AND AGGREGATION ON IMMOBILIZED PROTEIN C AND ACTIVATED PROTEIN C UNDER SHEAR
	-	THE LEECH PRODUCT SARATIN IS A POTENT INHIBITOR OF PLATELET INTEGRIN ALPHA2BETA1 AND VWF BINDING TO COLLAGEN
	-	THE THROMBIN MUTANT W215A/E217A ACTS AS A PLATELET ANTAGONIST THROUGH INHIBITION OF THROMBIN ACTIVATION AND GPIB BINDING TO VWF
	-	FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
Berrak S.G.	-	RECOMBINANT FVIIA USE IN THREE PRETERM NEONATES WITH DISSEMINATED INTRAVASCULAR COAGULATION
Berrou E.	-	PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION
	-	INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
Berruyer M.	-	ANTI-BETA 2 GLYCOPROTEIN I ANTIBODIES ASSAYS: USE OF MONOCLONAL ANTIBODIES FOR CALIBRATION
	-	MONITORING OF LOW MOLECULAR WEIGHT HEPARIN NADROPARIN DURING HEMODIALYSIS
Berry L.R.	-	CHEMOTHERAPY AFFECTS ACTIVATED PROTEIN C GENERATION TO A GREATER DEGREE IN NEWBORN THAN IN ADULT PLASMA
	-	INFLUENCE OF COVALENT ANTITHROMBIN-HEPARIN COMPLEX ON FIBROBLAST GROWTH FACTOR EXPRESSION AND LUNG ANGIOGENESIS
	-	EFFECT OF AGE ON THE RELATIONSHIP BETWEEN RATE OF HEPARIN-CATALYZED INHIBITION OF COAGULATION FACTORS BY ANTITHROMBIN AND IN VIVO PLASMA CONCENTRATION
	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX NEUTRALIZES PROCOAGULANT ACTIVITY INDUCED BY VENTILATION IN NEWBORNS
	-	DETERMINATION OF THROMBIN-ALPHA2MACROGLOBULIN COMPLEXES BY A NEW IMMUNO-ACTIVITY ASSAY
	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX REDUCES BRAIN EMBOLI DURING HYPOTHERMIC CARDIOPULMONARY BYPASS IN PIGS
Bertazzoni G.	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
Berthaut A.	-	BASAL EXPRESSION OF ENDOTHELIAL CELL PROTEIN C RECEPTOR IS REGULATED BY ENDOGENOUS ALDOSTERONE, PRODUCED VIA ALDOSTERONE SYNTHASE
Berthelsen L.O.	-	EFFECT OF MICROSPHERE EMBOLI ON THE VENTILATION-PERFUSION RELATIONSHIP IN THE RABBIT - A PILOT STUDY
Bertina R.M.	-	FUNCTIONALITY OF THE VASOPRESSIN 2 RECEPTOR VARIATION G12E AS MODIFIER OF VON WILLEBRAND FACTOR AND FACTOR VIII LEVELS
	-	SELECTIN HAPLOTYPES AND THE RISK OF VENOUS THROMBOSIS; INFLUENCE OF LINKAGE DISEQUILIBRIUM WITH THE FACTOR V LEIDEN MUTATION
	-	ASSOCIATION OF BLOOD PRESSURE AND FACTOR VIII IN LEIDEN THROMBOPHILIA STUDY (LETS) AND CARDIOVASCULAR HEALTH STUDY (CHS)
	-	FUNCTIONAL ANALYSIS OF SNPS SPECIFIC FOR HAPLOTYPE 1 (H1) OF THE GENE CODING FOR THE ENDOTHELIAL PROTEIN C RECEPTOR (EPCR)
	-	AQUAPORIN 2 GENE VARIATIONS, LEVELS OF VON WILLEBRAND FACTOR AND FACTOR VIII AND THE RISK OF VENOUS THROMBOSIS
	-	EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
	-	POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION
	-	THE EFFECT OF THE INTRONIC PROTHROMBIN 19911G ALLELE ON 3' END MRNA PROCESSING IN RELATION TO THE 20210GA POLYMORPHISM
	-	CIRCULATING MICROPARTICLE (MP)-ASSOCIATED TISSUE FACTOR (TF) ACTIVITY AND THROMBOSIS IN CANCER PATIENTS
	-	ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION
	-	FACTOR IX GENE VARIANTS AND THE RISK OF VENOUS THROMBOSIS
	-	PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION
	-	HAPLOTYPES OF THE C-REACTIVE PROTEIN GENE, PLASMA CRP LEVELS AND THE RISK OF MYOCARDIAL INFARCTION IN MEN
Bertolani L.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Bertolini A.	-	BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM
Bertolini F.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Bertolucci C.	-	COAGULATION FACTOR VII LEVELS ARE MODULATED BY THE BIOLOGICAL CLOCK
Bertomoro A.	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	A TYPE VICENZA-LIKE VON WILLEBRAND DISEASE NOT ASSOCIATED WITH VWF GENE MUTATION NOR ANTI-VWF ANTIBODIES
	-	A NEW (I1372S) MUTATION IN THE A1 DOMAIN OF VON WILLEBRAND FACTOR ASSOCIATED WITH A TYPE 2B-LIKE VON WILLEBRAND DISEASE PHENOTYPE
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
Bertoncello K.	-	HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
Bertoni A.	-	DEHYDROEPIANDROSTERONE INHIBITS PLATELET AGGREGATION
	-	EFFECTS OF 8-PRENYLNARINGENIN, A NOVEL PHYTOESTROGEN, ON HUMAN PLATELETS
	-	MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
Bertrand G.	-	NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO RARE PLATELET ALLOANTIGENS
Bertrand M.	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
Bertrand G.	-	PLATELET REFRACTORINESS DUE TO ANTI-HLA AND ANTI-HPA-5A ALLOANTIBODIES: CLINICAL MANAGEMENT DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Bertrand M.E.	-	DRUG ELUTING STENTS: RESTENOSIS VERSUS THROMBOSIS ?
Berzuini C.	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
Bespalova Z.D.	-	PAR1 AGONISTS ACCELERATE ULCER HEALING IN RATS
Besses C.	-	INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
Bessis D.	-	SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
Bestmann L.	-	COMPARISON OF THREE METHODOLOGIES TO ASSAY D-DIMER LEVELS IN SURGICAL PATIENTS: D DIMER ON MINIVIDAS VS. TINA-QUANT ON MODULAR P VS. TINA-QUANT ON BEHRING COAGULATION SYSTEM - A CALL FOR STANDARDISATION IN D-DIMER TESTING
Betafact Study Group	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HAEMOPHILIA B
Betancourt B.Y.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Bevan D.	-	SWITCHING PREVIOUSLY TREATED PATIENTS (PTPS) FROM PLASMA-DERIVED TO RECOMBINANT FACTOR VIII IN THE CONTEXT OF AN IMMUNOLOGICAL CHALLENGE CAN PROVOKE INHIBITOR FORMATION
Bevan S.	-	LABORATORY DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA: HELP OR HINDRANCE?
Bevan D.H.	-	SWITCHING PREVIOUSLY TREATED PATIENTS (PTPS) FROM PLASMA-DERIVED TO RECOMBINANT FACTOR VIII IN THE CONTEXT OF AN IMMUNOLOGICAL CHALLENGE CAN PROVOKE INHIBITOR FORMATION
Beyer J.	-	INCIDENCE AND DISEASE PATTERN OF VENOUS THROMBEMBOLISM AFTER RADICAL PROSTATECTOMY
Beyer J.J.B.	-	RESULTS OF A ONE-YEAR REGISTRY OF BLEEDING COMPLICATIONS OF VITAMIN K ANTAGONIST THERAPY OUTSIDE A CONTROLLED POPULATION
Beyer J.	-	HIT II-INDUCED CRITICAL LIMB ISCHAEMIA TREATED WITH UROKINASE AND ARGATROBAN
Beyersdorf F.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
Beyersdorf N.	-	AN EF-HAND MUTATION IN STIM1 CAUSES PREMATURE PLATELET ACTIVATION AND BLEEDING IN MICE
Beynon T.	-	VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM
Beynon H.	-	CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME PRESENTING WITH ISOLATED ANTI-BETA2 GLYCOPROTEIN I ANTIBODY POSITIVITY
Bezemer I.D.	-	FACTOR IX MALM IS ASSOCIATED WITH VENOUS THROMBOSIS
	-	MAJOR CHANGES IN THE DIAGNOSTIC WORK-UP OF PULMONARY EMBOLISM BETWEEN 1999 AND 2004
	-	TRENDS IN THE DIAGNOSTIC WORK-UP OF DEEP VENOUS THROMBOSIS OF THE LEG BETWEEN 1999 AND 2004
	-	GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
Beznos O.V.	-	FIBRINOLYTIC SYSTEM COMPONENTS IN RABBIT TEARS AFTER CHEMICAL BURN OF CORNEA
Bezzina Wettinger S.	-	`IN VIVO' TOLL-LIKE RECEPTOR 4 MRNA LEVELS ARE ASSOCIATED WITH RISK OF MYOCARDIAL INFARCTION IN MEN
Bhakta V.	-	EXTRA- AND INTRA-REACTIVE CENTRE LOOP ALTERATIONS TO ALPHA-1-PROTEINASE INHIBITOR ENHANCE ITS SPECIFIC INHIBITION OF THROMBIN
Bhat R.	-	BLEEDING AND THROMBOTIC COMPLICATIONS OF LIVER TRANSPLANTATION IN CHILDREN
	-	CHANGES IN HAEMOSTATIC FACTORS DURING AND AFTER LIVER TRANSPLANTATION IN CHILDREN
Bhatia G.	-	CARDIOVASCULAR RISK FACTORS ARE ASSOCIATED WITH PLASMA MARKERS OF PRO-ATHEROGENIC PROCESSES IN RHEUMATOID ARTHRITIS
Bhattacharjee G.	-	THE TISSUE FACTOR CYTOPLASMIC DOMAIN REGULATES PROCOAGULANT RESPONSES IN MACROPHAGES
Bhattacharya N.	-	PLATELET-FACILITATED DELIVERY OF ANGIOGENESIS REGLULATORS IS CONTROLLED BY TISSUE PROTEASES
Biagini S.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Bialonczyk C.	-	6 MONTHS VERSUS PROLONGED ANTICOAGULATION FOR PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH HIGH FACTOR VIII LEVELS
	-	EXCESS BODY FAT AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
Biancardi A.	-	807C/T POLYMORPHISM IN THE PLATELET GLYCOPROTEIN IA GENE IN PATIENTS WITH RETINAL VEIN OCCLUSION
Bianchi F.	-	NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO RARE PLATELET ALLOANTIGENS
Bianco G.A.	-	GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
Biasi G.M.	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
Biasoli C.	-	FVIII/VWF CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN ITALIAN HAEMOPHILIACS WITH NEGATIVE PREDICTORS OF ITI RESPONSE
	-	IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
Bichkova I.	-	THE CLINICAL RELEVANCE OF PLATELET HETEROGENEITY AND ACTIVATION IN PATIENT WITH ANTIPHOSPHOLIPID SYNDROME
Bick R.	-	UPREGULATION OF NITRIC OXIDE AND ASYMMETRIC DIMETHYLARGININE LEVELS IN MALIGNANCY ASSOCIATED THROMBOSIS AND THEIR MODULATION BY ANTICOAGULANTS
	-	DIFFERENTIAL ACTIVATION OF PROTHROMBIN BY FACTOR XA, TAIPAN VENOM AND ECARIN. PHARMACOLOGIC IMPLICATIONS
	-	RECOMBINANT THROMBOMODULIN DOES NOT CROSS REACT WITH ANTI-HEPARIN PLATELET FACTOR 4 ANTIBODIES. POTENTIAL IMPLICATION FOR ANTICOAGULATION OF HEPARIN-INDUCED THROMBOCYTOPENIA PATIENTS
	-	TRYPSIN MEDIATED ACTIVATION OF THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR (CARBOXYPEPTIDASE U)
	-	HEMODIALYSIS DOWN REGULATES THE INFLAMMATORY MEDIATORS IN PATIENTS WITH END STAGE RENAL DISEASE
	-	DOWN REGULATION OF THROMBOTIC AND INFLAMMATORY MEDIATORS IN PATIENTS WITH ACUTE CORONARY SYNDROME TREATED WITH CLOPIDOGREL. RELEVANCE TO THE OBSERVED CLINICAL EFFECTS
	-	DENGUE FEVER AND THROMBOCYTOPENIA: A DEADLY DUO
	-	ANTIINFLAMMATORY EFFECTS OF ARGATROBAN CAN BE DIFFERENTIATED FROM OTHER DIRECT THROMBIN INHIBITORS. EXPERIMENTAL AND CLINICAL OBSERVATIONS
	-	UPREGULATION OF INFLAMMATORY MEDIATORS IN LUNG CANCER AND THEIR MODULATION BY ORAL ANTICOAGULANT THERAPY
Bicocchi P.	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
Bidlingmaier C.	-	THE CHALLENGE OF PRAEOPERATIVE INVESTIGATION OF HEREDITARY AND ACQUIRED COAGULATION DISORDERS IN CHILDREN AND ADOLESCENTS
	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
	-	THE PTT IS NOT ENOUGH PREOPERATIVE COAGULATION SCREENING IN CHILDREN
Bidzhekov K.	-	BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION
Bieche I.	-	EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
	-	THROMBIN ADSORBED TO A FIBRIN CLOT CONFERS ANGIOGENIC AND HEMOSTATIC PROPERTIES ON ENDOTHELIAL PROGENITOR CELLS
Bieker R.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Biemond B.J.	-	MICROPARTICLES DURING THE COURSE OF PAINFUL CRISES IN SICKLE CELL DISEASE
	-	ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION
Bierhaus A.	-	FACTOR V LEIDEN PROTECTS AGAINST DIABETIC NEPHROPATHY IN MICE
	-	THE THROMBOMODULIN PROTEIN C SYSTEM PROTECTS AGAINST DIABETIC NEUROPATHY VIA TWO INDEPENDENT MECHANISMS
Biernat M.	-	THE ADDITIVE ANTIPLATELET ACTION OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH ASPIRIN
Biesert L.	-	PRION PROTEIN (PRPSC) REMOVAL BY CHROMATOGRAPHY PURIFICATION AND NANOFILTRATION OF FIXS AND PCC
	-	PRION PROTEIN REMOVAL DURING MANUFACTURING OF HIGH-PURITY VWF/FVIII CONCENTRATES
Biesma D.H.	-	THE CLINICAL VALIDATION OF A NEW QUANTITATIVE HIGH SENSITIVE D-DIMER ASSAY
Biesma D.	-	IL 1A 899C/T AND IL4 589C/T ARE ASSOCIATED WITH VENOUS THROMBOEMBOLISM
Biesma D.H.	-	EVALUATION OF TWO SOLUBLE FIBRIN MONOMER ASSAYS
	-	THE USE OF THE ENDOGENOUS THROMBIN POTENTIAL ASSAY IN THE DIAGNOSIS OF DEEP VENOUS THROMBOSIS
Biesma D.	-	THE VALUE OF PET- SCANNING IN THE DETECTION OF OCCULT CANCER IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Biglioli P.	-	TISSUE FACTOR INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 REQUIRES INTACT CAVEOLIN-ENRICHED MEMBRANE MICRODOMAINS IN HUMAN ENDOTHELIAL CELLS
	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
Bigorre M.	-	SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
Bigotto E.	-	PROTHROMBOTIC FACTORS AND OXIDATIVE STRESS MARKERS IN A TYPE 2 DIABETES POPULATION
	-	PROTHROMBOTIC FACTORS IN INFANTS WITH NEONATAL CEREBRAL INFARCTION
Bigsby G.	-	HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
Biguzzi E.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
	-	INTERFERENCE OF FACTOR V LEIDEN ON PROTEIN S ACTIVITY. EVALUATION OF A NEW PROTHROMBIN TIME-BASED ASSAY
Bihan D.	-	IDENTIFICATION OF CRITICAL RESIDUES IN A GPVI BINDING PEPTIDE
	-	GENERATION OF INTERMEDIATE AFFINITY FORMS OF 2 I DOMAIN
Bijlsma M.F.	-	COAGULATION FACTOR XA INHIBITS CANCER CELL MIGRATION VIA LIMK1-MEDIATED COFILIN INACTIVATION
Bila J.S.	-	EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION
Bilderbeek-Beckers M.A.L.	-	MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
Bilgen H.	-	RECOMBINANT FVIIA USE IN THREE PRETERM NEONATES WITH DISSEMINATED INTRAVASCULAR COAGULATION
Billeci A.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Billett H.H.	-	LMWH BRIDGING FOR ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
Billiald P.	-	GENERATION AND CHARACTERIZATION OF A RECOMBINANT BLOCKING ANTI-GLYCOPROTEIN VI SINGLE CHAIN ANTIBODY FRAGMENT
Bilora F.	-	ENDOTHELIAL DYSFUNCTION IN HEMOPHILIA PATIENTS
Binard S.	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Binder B.R.	-	ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER
	-	REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
Binder C.J.	-	ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
Binder E.B.	-	ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
Binder B.R.	-	ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
	-	MEASUREMENT OF THROMBIN GENERATION IN PATIENTS AT RISK FOR ATHEROTHROMBOSIS
	-	LIPIDS, MICROPARTICLES AND COAGULATION FACTORS AS DETERMINANTS OF LAG PHASE AND RATE OF THROMBIN GENERATION IN PLASMA
	-	MICROPARTICLES IN THROMBIN GENERATION - A SIGNIFICANT PARAMETER INFLUENCING PEAK THROMBIN LEVELS
	-	THROMBOGENICITY OF MICROPARTICLES DERIVED FROM VASCULAR CELLS
	-	UROKINASE (UPA) INDUCES ENDOTHELIAL CELL SURVIVAL VIA THE X-LINKED INHIBITOR OF APOPTOSIS PROTEIN (XIAP)
Binet A.	-	ABCIXIMAB-DEPENDENT THROMBOCYTOPENIA IN PATIENTS WITH ACUTE CORONARY SYNDROMES CAN OCCUR BY DIFFERENT MECHANISMS
Binetti B.M.	-	HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH APC RESISTANCE
	-	PLASMA FIBRINOLYTIC POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
Biondo F.	-	PHARMACOKINETICS OF THE REFORMULATED B-DOMAIN DELETED RECOMBINANT FACTOR VIII (BDD-RFVIII) CONCENTRATE USING CHROMOGENIC AND ONE-STAGE ASSAYS WITH POOLED NORMAL PLASMA (PNP) AND REFACTO LABORATORY STANDARD (RLS)
Birch N.	-	CHARACTERISATION OF RZPI PRODUCED IN ESCHERICHIA COLI
Birenbaum J.	-	MONOCLONAL ANTIBODIES THAT MIMIC ANTIBODIES FOUND IN PATIENTS WITH DRUG (QUININE(QN))-INDUCED IMMUNE THROMBOCYTOPENIA (DITP): IMPLICATIONS FOR THE PATHOGENESIS OF DITP
Birgit Stoffel-Wagner B.	-	INFLUENCE OF PERINATAL RISK FACTORS ON THE DEVELOPMENT OF PLASMATIC COAGULATION IN EXTREMELY PRETERM INFANTS
Biro E.	-	ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V
	-	CELL-DERIVED MICROPARTICLES AND COMPLEMENT ACTIVATION IN PREECLAMPSIA VERSUS NORMAL PREGNANCY
Biron C.	-	THE IMPORTANCE OF TYPE OF QUALITY CONTROL WHEN CHANGING REAGENT BATCHES
Biron-Andreani C.	-	ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES
Birschbach K.	-	PROTEOMIC ANALYSIS IN PLATELET DYSFUNCTION
Birschmann I.	-	ANALYSIS OF THE INTERACTOME IN HUMAN PLATELETS
Birtwistle L.	-	IN VIVO RECOVERY OF RISTOCETIN CO-FACTOR IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERGOING PROCEDURES REQUIRING TREATMENT WITH HAEMATE P
Bis J.C.	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
Biss T.T.	-	USE OF RECOMBINANT FACTOR VIIA (RFVIIA) IN THE MANAGEMENT OF MAJOR HAEMORRHAGE - A SURVEY OF CURRENT UK PRACTICE
	-	CLINICAL CHARACTERISTICS OF PULMONARY EMBOLISM IN CHILDHOOD- EXPERIENCE FROM A SINGLE CENTRE
Biswas T.K.	-	FUNCTIONAL ELISA OF VON WILLEBRAND FACTOR (VWF) ACTIVITY USING HIS-TAGGED INCREASE-OF-FUNCTION RECOMBINANT GPIB BOUND TO NICKEL CHELATE PLATES
	-	RISTOCETIN-INDUCED AGGREGATION OF HUMAN GPIBALPHA TRANSGENIC MICE IS INHIBITED BY ANTI-HUMAN GPIBALPHA ANTIBODIES IN THE PRESENCE OF HUMAN PLASMA
Bitonti A.J.	-	ENHANCED PHARMACOKINETICS OF FACTOR IX AS A MONOMERIC FC FUSION
Bitsadze V.O.	-	PROPHYLAXIS OF RECURENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA
	-	PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PREGNANT WOMEN WITH THROMBOPHILIA
	-	PATHOGENETIC PROPHYLAXIS OF RECCURENT FETAL LOSS SYNDROME IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND GENETIC THROMBOPHILIA
	-	ANTIPHOSPHOLIPID ANTIBODIES SPECTRUM IN WOMEN WITH RECCURENT FETAL LOSS SYNDROME
Bjerke M.	-	PLATELET ACTIVATION VIA THROMBIN RECEPTOR PAR4 IS INVOLVED IN THE INITIATION OF THROMBIN GENERATION AND COAGULATION AND IN CLOT ELASTICITY DEVELOPMENT
Bjerkeli V.	-	HUMAN PLATELETS AND MEGAKARYOCYTES CONTAIN FACTOR X mRNA, DETECTED WITH REAL-TIME QUANTITATIVE RT-PCR
Björck K.	-	EFFECT OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 ON GLOMERULAR FILTRATION RATE IN ELDERLY HEALTHY SUBJECTS
Bjorkman S.	-	BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
	-	BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
Björkman J.A.	-	REDUCED BLEEDING TIME PROLONGATION FOR THE REVERSIBLE P2Y12 ANTAGONIST AZD6140 COMPARED WITH THE THIENOPYRIDINE, CLOPIDOGREL, IN BOTH A RAT AND DOG MODEL OF COMBINED THROMBOSIS AND HEMOSTASIS
	-	CARDIAC tPA RELEASE DURING SYMPATHETIC NERVE STIMULATION IN PIGS DECREASES BY REPEATED STIMULATIONS
Bjørn S.E.	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
	-	DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
Bjørnsen S.	-	HUMAN PLATELETS AND MEGAKARYOCYTES CONTAIN FACTOR X mRNA, DETECTED WITH REAL-TIME QUANTITATIVE RT-PCR
Black K.	-	ACCURACY OF THE COAGUCHEK XS FOR POC INR IN CHILDREN REQUIRING WARFARIN
Black L.	-	DO WE NEED DIFFERENT STANDARD CURVES FOR MEASURING DIFFERENT LOW MOLECULAR WEIGHT HEPARINS?
Black K.	-	KNOWLEDGE RETENTION IMPROVES OUTCOMES FOR CHILDREN REQUIRING VITAMIN K ANTAGONISTS
Blackburn J.C.	-	EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS
Blackney M.	-	FLOVAGATRAN (TGN 255), BIVALIRUDIN AND MELAGATRAN - DIFFERENTIAL PHARMACOLOGICAL EFFECTS ON THROMBIN GENERATION
Bladin C.	-	ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
Blagojevic E.	-	THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
Blaha M.	-	MODIFIED PLATELETS FUNCTION ANALYSIS TO RATIONALIZE CHOLESTEROL ELIMINATION PROCEDURE
Blaha V.	-	MODIFIED PLATELETS FUNCTION ANALYSIS TO RATIONALIZE CHOLESTEROL ELIMINATION PROCEDURE
Blair I.	-	IDENTIFICATION OF NOVEL PLATELET MEMBRANE PROTEINS USING MULTI-DIMENSIONAL PROTEIN IDENTIFICATION TECHNOLOGY
Blake C.M.	-	ANTIDOTE REVERSAL OF A NOVEL ANTICOAGULANT DECREASES MORTALITY AND IMPROVES NEUROLOGICAL FUNCTION IN A MURINE MODEL OF SUBARACHNOID HEMORRHAGE
Blamey C.J.	-	THE CENTRAL LINKER OF CALCIUM- AND INTEGRIN-BINDING PROTEIN 1 FUNCTIONS AS A TETHER AND IS CRITICAL FOR BINDING THE CYTOPLASMIC TAIL OF THE INTEGRIN ALPHA IIB SUBUNIT
Blanchette V.	-	BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
	-	BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
Blanchette V.S.	-	BERNARD-SOULIER PLATELETS EXPOSE MORE PROCOAGULANT PHOSPHATIDYLSERINE (PS), WITH PAR1 AND PAR4 MEDIATING THE SYNERGISTIC EFFECT OF THROMBIN ON COLLAGEN-STIMULATED PS EXPRESSION
	-	PLATELET FUNCTION THROMBOELASTOGRAPHY (PFT)
Blanco A.N.	-	BIOLOGICAL AND CLINICAL RESPONSE TO DESMOPRESSIN IN CHILDREN WITH VON WILLEBRAND DISEASE
Blanco A.	-	IS THERE ANY CORRELATION BETWEEN FIBRINOLYTIC ACTIVITY AND BLEEDING SCORE IN TYPE 1 AND POSSIBLE TYPE 1 VON WILLEBRAND DISEASE?
Blanco A.N.	-	POISONING WITH SUPERWARFARIN
	-	FACTOR XIII DEFICIENCY: SYMPTOMS, DIAGNOSIS AND LONG-TERM REPLACEMENT THERAPY
	-	ANTITHROMBIN (AT): A CONFORMATIONAL VARIANT?
	-	DIAGNOSIS AND FOLLOW UP OF FACTOR XIII DEFICIENCY: COMPARISON OF DIFFERENT CLOT-SOLUBILITY TESTS
Blangero J.	-	MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT
Blangero J.C.	-	GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Blangero J.	-	GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
Blann A.	-	EFFECT OF VITAMIN K FOR WARFARIN REVERSAL ON ELEMENTS OF THE TISSUE FACTOR PATHWAY
Blann A.D.	-	ANGIOGENESIS IN RHEUMATOID ARTHRITIS: IS IT RELATED TO ENDOTHELIAL PERTURBATION AND/OR INFLAMMATION?
	-	RAISED CIRCULATING ENDOTHELIAL CELLS IN RHEUMATOID AND EARLY ARTHRITIS
	-	CARDIOVASCULAR RISK FACTORS ARE ASSOCIATED WITH PLASMA MARKERS OF PRO-ATHEROGENIC PROCESSES IN RHEUMATOID ARTHRITIS
Blasi F.	-	THE UROKINASE RECEPTOR: CELL MIGRATION, CELL PROLIFERATION AND CANCER
Blass A.	-	SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
Blatny J.	-	RFVIIA IS EFFECTIVE ALTERNATIVE TO APCC IN PROPHYLAXIS OF BLEEDING DURING IMMUNE TOLERANCE PROTOCOL IN HAEMOPHILIAC WITH INHIBITOR
	-	FIRST INTERIM ANALYSIS OF SEVEN BLEEP REGISTRY FOCUSED ON EFFICACY AND SAFETY OF THE TREATMENT WITH RFVIIA IN MASSIVE HAEMORRHAGE IN CHILDREN
	-	IS IT POSSIBLE TO TREAT SAFELY AND EFFECTIVELY DEEP VEIN THROMBOSIS WITH CONTINUOUS I.V. INFUSION OF LMWH IN CHILDREN?
Blauth G.	-	UNEXPLAINED PROLONGED PLATELET FUNCTION ANALYZER (PFA-100) CLOSURE TIME INDUCED BY SAMPLE ANTICOAGULANT
Blautzik J.	-	THE THROMBOMODULIN PROTEIN C SYSTEM PROTECTS AGAINST DIABETIC NEUROPATHY VIA TWO INDEPENDENT MECHANISMS
Blazar B.R.	-	ANTI-ICOS IMMUNOTHERAPY PREVENTED INHIBITORY ANTIBODY FORMATION AGAINST FACTOR VIII FOLLOWING NONVIRAL GENE TRANSFER IN HEMOPHILIA A MICE
Blazek M.	-	MODIFIED PLATELETS FUNCTION ANALYSIS TO RATIONALIZE CHOLESTEROL ELIMINATION PROCEDURE
Blemings A.	-	INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
Blickstein D.	-	ANTI-CD 20 MONOCLONAL ANTIBODY (RITUXIMAB) AS AN OPTIONAL TREATMENT FOR INTRACTABLE ACQUIRED GLANZMANN THROMBASTHENIA
Bliden K.P.	-	IS THE ASSESSMENT OF CLOPIDOGREL RESPONSIVENESS AFFECTED BY THE ANTICOAGULANT OR MEASUREMENT OF MAXIMUM PLATELET AGGREGATION OR FINAL PLATELET AGGREGATION?
Bliden K.	-	SYNERGISTIC EFFECT OF SMOKING ON PLATELET RESPONSIVENESS TO CLOPIDOGREL
Bliden K.P.	-	PLATELET FUNCTION MEASURED BY VERIFYNOW IDENTIFIES GENERALIZED HIGH PLATELET REACTIVITY IN ASPIRIN TREATED PATIENTS
	-	MYONECROSIS IS PREDICTED BY HIGH REACTIVITY TO MULTIPLE PLATELET AGONISTS: A TRANSLATIONAL STUDY OF PATIENTS UNDERGOING STENTING TREATED WITH BIVALIRUDIN AND HIGH DOSE CLOPIDOGREL
	-	TRANSITION TO AN UNSTABLE CORONARY SYNDROME IS MARKED BY HYPERCOAGUABILITY, PLATELET ACTIVATION, HEIGHTENED PLATELET REACTIVITY, AND INFLAMMATION: RESULTS OF THE THROMBOTIC RISK PROGRESSION (TRIP) STUDY
	-	RELATION OF PLATELET-FIBRIN CLOT STRENGTH, PLATELET REACTIVITY, INFLAMMATION AND GROWTH FACTOR RELEASE TO THROMBOTIC RISK IN PATIENTS UNDERGOING STENTING
	-	VULNERABLE BLOOD MEASURED BY THROMBELASTOGRAPHY: A PREDICTOR OF TARGET LESION REVASCULARIZATION AFTER CORONARY STENTING
	-	DO WE COMPLETELY UNDERSTAND THE ANTITHROMBOTIC EFFECT OF ASPIRIN?
	-	EFFECTS OF DIABETES ON THE PREVALENCE OF ASPIRIN RESISTANCE DURING LOW DOSE ASPIRIN THERAPY
	-	POST - CORONARY INTERVENTION RECURRENT ISCHEMIA IN THE PRESENCE OF ADEQUATE PLATELET INHIBITION BY DUAL ANTIPLATELET THERAPY: WHAT ARE WE OVERLOOKING?
	-	THE RELATION OF HIGH EX VIVO THROMBOGENIC POTENTIAL TO HIGH ISCHEMIC RISK IN AFRICAN AMERICAN WOMEN UNDERGOING CORONARY STENTING
	-	SUPERIOR EFFECT OF EPTIFIBATIDE ADDED TO CLOPIDOGREL ON BIOMARKER EXPRESSION DETECTED BY FLUOROKINE MULTI-ANALYTE PROFILING IN PATIENTS UNDERGOING ELECTIVE PCI
	-	BIOMARKER ANALYSIS BY FLUOROKINE MULTI-ANALYTE PROFILING DISTINGUISHES PATIENTS REQUIRING INTERVENTION FROM PATIENTS WITH LONG-TERM QUIESCENT CORONARY ARTERY DISEASE: A POTENTIAL APPROACH TO IDENTIFY ATHEROSCLEROTIC DISEASE PROGRESSION
	-	EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI
Bliden K.	-	LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY)
Bliden K.P.	-	INHIBITION OF PLATELET AGGREGATION: A NOVEL EFFECT OF C-REACTIVE PROTEIN
	-	PATIENTS WITH METABOLIC SYNDROME DEMONSTRATE HIGH PLATELET REACTIVITY AND INCREASED PROCOAGULANT MARKERS
Blinc A.	-	T1-WEIGHTED MAGNETIC RESONANCE IMAGING DIFFERENTIATES PLATELETS IN PULMONARY EMBOLI EX VIVO
Blinov M.N.	-	APOE GENE POLYMORPHISM CAN MODIFY THE RISK OF VENOUS THROMBOEMBOLISM
	-	THE ROLE OF DNA POLYMORPHISMS IN GENES CODING THE HOMOCYSTEINE AND FOLATE METABOLIZING ENZYMES IN ISCHAEMIC HEART DISEASE
	-	GENETIC POLYMORPHISM OF THE PLATELET ADP-RECEPTOR P2Y12 MODIFIES THE RISK OF PULMONARY EMBOLISM IN PATIENTS WITH DEEP-VEIN THROMBOSIS
Block A.	-	HETEROGENEITY WITHIN THE PROTEIN CONTENT OF SECRETORY ORGANELLES OF HUMAN PLATELETS
Blocklet D.	-	USEFULNESS OF PERFUSION LUNG SCAN COMBINED WITH CLINICAL ASSESSMENT TO RULE OUT PULMONARY EMBOLISM
Blom H.J.	-	CATECHOL-O-METHYLTRANSFERASE GENOTYPE IS ASSOCIATED WITH PLASMA TOTAL HOMOCYSTEINE LEVELS AND MAY INCREASE RECURRENT VENOUS THROMBOSIS RISK
	-	SINGLE AND COMBINED EFFECTS OF GENE VARIANTS ON PLASMA TOTAL HOMOCYSTEINE LEVELS: RESULTS OF A CANDIDATE GENE APPROACH IN A POPULATION SAMPLE
	-	B-VITAMIN SUPPLEMENTATION LOWERS PLASMA HOMOCYSTEINE CONCENTRATION BUT DOES NOT AFFECT PLASMA METHIONINE AND CYSTEINE CONCENTRATIONS: A POSSIBLE EXPLANATION FOR NEGATIVE RESULTS OF CLINICAL TRIALS
	-	ANALYSIS OF FOLATE-RELATED GENES FOR ASSOCIATION WITH PLASMA HOMOCYSTEINE LEVEL IN A SNP-MICROARRAY APPROACH
Blombäck M.	-	MEASUREMENTS OF FIBRINOGEN AND CRP CONCENTRATIONS IN EDTA AND CITRATE PLASMA
Blomback M.	-	EFFECTS OF ARGATROBAN A THROMBIN INHIBITOR - ON THE FIBRIN GEL PERMEABILITY AND THE HEMOSTASIS BALANCE IN PLASMA
	-	INCREASED FIBRINOLYISIS ASSOCIATED WITH DEFECTIVE COAGULATION CONTRIBUTES TO IMPAIRMENT OF HEMOSTASIS IN HEMOPHILIA
Blomstrand C.	-	FIBRINOGEN HAPLOTYPES AND PLASMA LEVELS SHOW INDEPENDENT ASSOCIATION TO ISCHEMIC STROKE
Blostein M.	-	ELEVATED PLASMA GAS6 LEVELS ARE ASSOCIATED WITH CLOT BURDEN AND UNDERLYING MALIGNANCY IN DEEP-VEIN THROMBOSIS
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
Blostein M.D.	-	THROMBELASTOGRAPHY STUDY OF HEMOSTATIC AGENTS
	-	THE IMPORTANCE OF THE PROPEPTIDE FOR CARBOXYLATION OF THE VITAMIN K DEPENDENT CLOTTING FACTORS: STUDIES WITH FACTOR IX
Blostein M.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
	-	THE EFFECT OF ANTICOAGULANTS ON CANCER RISK AND SURVIVAL: SYSTEMATIC REVIEW
Blum R.	-	OPTIMIZING CARE VIA INTERNET-BASED HEMOPHILIA THERAPY MANAGEMENT PLATFORM
Bluteau D.	-	FROM HEMATOPOIETIC STEM CELLS TO PLATELETS
Boadas A.	-	USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS
Bobbert P.	-	VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Bobbio Pallavicini E.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Bobe R.	-	CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS
Bobrovnik S.A.	-	NONSPECIFIC BINDING OF CIRCULATED IMMUNOGLOBULINS TO THE ENDOTHELIAL SELLS OF BLOOD VESSELS
Boccalon H.	-	LATE BREAKING CLINICAL TRIAL: ANTICOAGULANT CLINICS-BASED SHARED-CARE VERSUS GENERAL PRACTITIONERS MANAGEMENT OF ORAL ANTICOAGULANTS: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY
Boccara C.	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
Bocchi L.	-	CARDIOVASCULAR DISEASE, HYPERHOMOCYSTEINEMIA AND ATHEROTHROMBOTIC RISK FACTORS IN PSORIATIC PATIENTS
	-	EFFICACY AND SAFETY OF HIGH DOSES OF FEIBA FOR MAJOR SURGERY IN A PATIENT WITH HAEMOPHILIA A AND HIGH-TITRE INHIBITOR
	-	THROMBOTIC MARKERS AND MITRAL VALVE PROLAPSE IN MIGRAINE WITH AND WITHOUT AURA AT CHILDHOOD ONSET
Bochkov V.	-	THROMBOGENICITY OF MICROPARTICLES DERIVED FROM VASCULAR CELLS
	-	REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
Bochkov V.N.	-	GENETIC POLYMORPHISM R353Q OF FACTOR VII HAS PROTECTIVE EFFECT IN THREATENED MISCARRIAGE
Bock P.E.	-	VON WILLEBRAND FACTOR BINDING PROTEIN IS A NOVEL CONFORMATIONAL ACTIVATOR OF PROTHROMBIN
Bock S.C.	-	ENHANCED HEPARIN BINDING AFFINITIES INCREASE THE EFFICIENCIES AT WHICH THE BETA-ANTITHROMBIN III ISOFORM AND A RECOMBINANT ATIII VARIANT LOAD ONTO PENTASACCHARIDE-BEARING SURFACES UNDER FLOW
	-	REMOVAL OF THE POSITIVE CHARGE BUT NOT THE HYDROPHOBIC STEM FROM LYSINE-222 IN ANTITHROMBIN III BETA-SHEET-A REDUCES FACTOR XA INHIBITION RATES AND INCREASES HEPARIN BINDING AFFINITY
Bock P.E.	-	SKIZZLE, A NOVEL PLASMIN(OGEN) BINDING PROTEIN AND PLASMINOGEN ACTIVATOR FROM STREPTOCOCCUS AGALACTIAE
	-	EXOSITES IN THE SUBSTRATE SPECIFICITY OF BLOOD COAGULATION REACTIONS
	-	THE ROLE OF THROMBIN EXOSITES I AND II IN THE ACTIVATION OF HUMAN COAGULATION FACTOR V
Bock S.C.	-	CONCURRENT RELEASE OF NATIVE CONFORMATION REACTIVE CENTER LOOP AND HELIX D STRAND 2A STRUCTURAL CONSTRAINTS FULLY ACTIVATES ANTITHROMBIN III IN THE ABSENCE OF HEPARIN
	-	THE ANTITHROMBIN III SERINE-380 P14 HYDROXYL MAKES CRITICAL CONTRIBUTIONS TO METASTABILITY OF THE NATIVE CONFORMATION AND TO STABILIZATION OF THE HEPARIN-BOUND ACTIVATED STATE
Bockenstedt P.	-	ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN THE THROMBOPHILIA PILOT PROJECT
	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Bockmeyer C.L.	-	EXPRESSION AND SECRETION OF ADAMTS13 IS INHIBITED BY PROINFLAMMATORY STIMULATION
Boda Z.	-	LOW DOSE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE PROPHYLAXIS OF A PATIENT WITH ACQUIRED HAEMOPHILIA AFTER UNSUCCESSFUL ERADICATION THERAPY
	-	A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
	-	SUCCESSFUL IMMUNE TOLERANCE INDUCTION TREATMENT OF THERAPY-RESISTENT ACQUIRED HAEMOPHILIA WITH HIGH INHIBITOR TITER: A CASE REPORT
	-	COULD HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS BE A RARE MANIFESTATION OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME?
Boddi M.	-	GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
Bode C.	-	CONFORMATION-SPECIFIC BLOCKADE OF THE INTEGRIN GPIIB/IIIA): IN VITRO AND IN VIVO RESULTS DEMONSTRATING A SELECTIVE PLATELET BLOCKADE WITH LESS ADVERSE EFFECTS
	-	EVIDENCE FOR AN ALTERNATIVE REGULATION OF THE ACTIVITY OF THE BETA3-INTEGRIN ALPHAVBETA3 IN THE ABSENCE OF THE HIGHLY CONSERVED ALPHA-SUBUNIT GFFKR MOTIF
	-	MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
Bodzenta-Lukaszyk A.	-	PLASMIN SYSTEM REGULATION IN OVA-SENSITIZED RAT MODEL OF ASTHMA
Boehlen F.	-	ANTIPHOSPHOLIPID ANTIBODIES AND TLR2 COLOCALIZED IN HUVEC ENDOSOMES
	-	PLATELET REFRACTORINESS DUE TO ANTI-HLA AND ANTI-HPA-5A ALLOANTIBODIES: CLINICAL MANAGEMENT DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
	-	DIFFERENCES IN ENDOTHELIAL CELL ACTIVATION BY IGG FROM PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME OR WITH IMMUNE THROMBOCYTOPENIC PURPURA
Boehm B.O.	-	THE Y2561 ALLELE OF A COMMON POLYMORPHISM IN THE C1 DOMAIN OF VON WILLEBRAND FACTOR APPEARS AS A NOVEL RISK FACTOR FOR MYOCARDIAL INFARCTION
	-	LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Boehncke W.H.	-	CUTANEOUS DELAYED-TYPE IV-HYPERSENSITIVITY REACTION (DTH) TO HEPARIN AND HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II (HIT) IS THERE AN ASSOCIATION ?
Boeken P.	-	HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
Boekhorst J.	-	THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE
	-	THE ROLE OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) AND MEGALIN RECEPTOR IN THE CLEARANCE OF FACTOR VIII IN HUMANS
Boezeman J.	-	ANTIPHOSPHOLIPID ANTIBODIES DISTURB 2D LATTICE FORMATION OF ANNEXINE A5 ON ACTIVATED PLATELETS
	-	THE DUAL ROLE OF INTRINSIC GENERATED PLASMIN IN THE REGULATION OF THE HEMOSTATIC BALANCE
Boffito M.	-	ACUTE EFFECT OF STATINS ON THE REGULATION AND EXPRESSION OF CANDIDATE GENES (CD36, MMP-9 AND IL-8) IN ATHEROSCLEROSIS IN HIV-INFECTED PATIENTS
Bogard M.	-	FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Bogdanov V.Y.	-	NATURALLY OCCURRING TF VARIANTS ARE PRESENT IN BLOOD OF FVB/N MICE: THE MKR MODEL OF TYPE 2 DIABETES IS WELL SUITED FOR DEVELOPMENT OF A TF-BASED MODEL OF DIABETIC THROMBOPHILIA
Bogdanov I.G.	-	LYMPHOCYTE PLATELET ADHESION IN THROMBOPHILIC PATIENTS WITH LUNG SURGERY
Bogdanova A.S.	-	LYMPHOCYTE PLATELET ADHESION IN THROMBOPHILIC PATIENTS WITH LUNG SURGERY
Bogdanova N.	-	EFFECTS OF THE FACTOR V G1691A MUTATION AND THE FACTOR II G20210A VARIANT ON THE CLINICAL EXPRESSION OF SEVERE HEMOPHILIA A ( 1%) IN CHILDREN
Boge G.	-	CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
Boggio L.N.	-	THE USE OF ADVATE IN LIVER AND KIDNEY TRANSPLANTATION IN A PATIENT WITH HEMOPHILIA A, HEPATITIS C, AND HIV
Bogutchi T.	-	MANAGING SUSPECTED VENOUS THROMBOEMBOLISM IN A MIXED PRIMARY AND SECONDARY CARE SETTING USING STANDARD CLINICAL ASSESSMENT AND D-DIMER IN A NON-INVASIVE DIAGNOSTIC STRATEGY
	-	DURATION OF SYMPTOMS AND D-DIMER TESTING FOR VENOUS THROMBOEMBOLISM RULING-OUT
Bohgaki T.	-	DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
Bohlmann M.	-	THROMBOPHILIA AND SPONTANEOUS ABORTION THERAPY WITH LMW-HEPARI
Böhm F.	-	NO EFFECT OF LIPID LOWERING BY SIMVASTATIN OR SIMVASTATIN AND EZETIMIBE ON PLATELET FUNCTION IN PATIENTS WITH TYPE 2 DIABETES OR IMPAIRED GLUCOSE TOLERANCE AND CORONARY ARTERY DISEASE
Böhm B.	-	ENDOGENOUS THROMBIN POTENTIAL IN 3183 PARTICIPANTS OF THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
Böhm-Weigert M.	-	MILD CONGENITAL ADAMTS13 DEFICIENCY DUE TO ONE MISSENSE MUTATION TOGETHER WITH FOUR AMINO ACID POLYMORPHISMS IN A PATIENT WITH FAMILIAL RECURRENT ISCHEMIC STROKE
Boiko E.V.	-	CHANGES IN PLATELET HAEMOSTASIS IN PATIENTS WITH ACUTE ACETIC ACID POISONING
Böing A.N.	-	COAGULANT PROPERTIES OF MICROPARTICLE-ASSOCIATED FUSION PRODUCTS OF FULL LENGTH AND ALTERNATIVELY SPLICED HUMAN TISSUE FACTOR WITH GREEN FLUORESCENT PROTEIN
	-	PLATELET MICROPARTICLES CONTAIN ACTIVE CASPASE 3
	-	INHIBITION OF MICROPARTICLE RELEASE TRIGGERS ENDOTHELIAL APOPTOSIS
	-	SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT
Boinot C.	-	INCIDENCE OF ANTITHROMBIN LEVEL ON "HEMOFILTER CIRCUIT" THROMBOSIS DURING EARLY CONTINUOUS VENOVENOUS HEMOFILTRATION IN POST CARDIOPULMONARY BYPASS PATIENTS
	-	IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Boisen M.	-	REDUCTION OF DIABETES-RELATED LIPID OXIDATIVE STRESS BY STATIN THERAPY AS MONITORED BY SERUM OXIDIZED LDL/B2GPI COMPLEX LEVELS
	-	ASSOCIATION OF IGG ANTI-OXLDL/B2GPI AND B2GPI-DEPENDENT ANTI-CARDIOLIPIN (ACL) ANTIBODIES WITH VASCULAR THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)
Boisseau P.	-	CAN THROMBIN GENERATION BE HELPFUL TO EVALUATE THE BLEEDING PHENOTYPE IN MILD HEMOPHILIA A WITH FACTOR VIII ASSAY DISCREPANCY?
Boisson-Vidal C.	-	EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
Boka V.	-	DNR ANALYSIS RESULTS IN THROMBOSES PATIENTS: THE FIRST DATA IN LATVIA
Bokarewa M.	-	IL-1BETA-INDUCED TISSUE-TYPE PLASMINOGEN ACTIVATOR SUPPRESSION IN VASCULAR ENDOTHELIAL CELLS IS MEDIATED BY NF-KAPPAB SIGNALING
Bokeria L.A.	-	USE OF RECOMBINANT FACTOR VIIA IN CARDIOSURGERY PATIENTS, INCLUDING NEONATES AND INFANTS UNDER 1 YEAR OF AGE
Boldrin M.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Boldueva S.A.	-	HYPERHOMOCYSTEINEMYA IS COMMON IN ACUTE CORONARY SYNDROMES IN NORTH-WESTERN RUSSIA
Bolli P.	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
	-	HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
Bolli G.B.	-	RAPID INCREASE OF EXPRESSION OF INDUCIBLE CYCLOOXYGENASE (COX-2) IN MONOCYTES OF PATIENTS WITH TYPE II DIABETES MELLITUS (T2DM) EXPOSED IN VIVO TO HYPERGLYCEMIC SPIKES
Bolli P.	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
	-	HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
Bolt G.	-	FACTOR VIII A2 DOMAIN INTERACTION WITH LRP: IN VITRO AND IN VIVO ANALYSES
Bolte O.	-	SUCCESSFUL TREATMENT OF PATIENTS WITH INHIBITORS TO COAGULATION FACTOR VIII AND IX BY TREATING CONCOMITANT HEPATITIS C
Bolton-Maggs P.	-	DETECTION OF PARTIAL F8 GENE DELETIONS IN HAEMOPHILIA A CARRIER DIAGNOSIS
	-	IN VIVO RECOVERY OF RISTOCETIN CO-FACTOR IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERGOING PROCEDURES REQUIRING TREATMENT WITH HAEMATE P
Boltz M.	-	EVOLUTIONARY CONSERVED B-DOMAIN SEQUENCES CONTRIBUTE TO MAINTAINING FACTOR V AS A PROCOFACTOR
Boltzen U.	-	VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Bomgaars L.R.	-	PREVALENCE OF "ASPIRIN RESISTANCE" IN CHILDREN
Bomgaars L.	-	FACTOR V AND THROMBIN INHIBITORS IN CHILDREN FOLLOWING BOVINE THROMBIN EXPOSURE
Bon C.	-	INR STANDARDIZATION: FRENCH EXPERIENCE OF AN EXTERNAL QUALITY ASSESSMENT PROGRAM
Bonanni E.	-	HAEMOSTATIC AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS: EFFECT OF TUMOR NECROSIS FACTOR ALPHA BLOCKADE
Bonar R.	-	2B OR NOT 2B? DISPARATE DISCRIMINATION OF FUNCTIONAL VWF DISCORDANCE USING DIFFERENT ASSAYS OR METHODOLOGIES FOR VWF LEADS TO SUCCESS OR FAILURE IN THE EARLY IDENTIFICATION OF TYPE 2B VWD
Boncela J.	-	KU80 AS A NOVEL RECEPTOR FOR THYMOSIN BETA4 THAT MEDIATES ITS INTRACELLULAR ACTIVITY DIFFERENT FROM G ACTIN SEQUESTERING
Boncela J.M.	-	REGULATORY EFFECT OF ALPHA1-ACID GLYCOPROTEIN ON PAI-1 REDISTRIBUTION ON ENDOTHELIAL CELLS SURFACE
Boncheva M.I.	-	ROTATION THROMBELASTOGRAPHY APPROACH DURING LIVER TRANSPLANTATION
Bondarenco S.N.	-	D-DIMER IN PATIENTS WITH ACUTE LEUKEMIA AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS
Bonduel M.M.	-	POST-INFECTIOUS PURPURA FULMINANS (PF): 12 YEAR-EXPERIENCE AT A SINGLE ARGENTINEAN CENTER
	-	USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
	-	TYPE 2B VON WILLEBRAND'S DISEASE. REPORT FROM A SINGLE CENTER IN ARGENTINA
Bonello L.	-	ENDOTHELIAL MARKERS OF INJURY/REPAIR EQUILIBRIUM IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
	-	VASP PHOSPHORYLATION ANALYSIS PRIOR TO PERCUTANEOUS CORONARY INTERVENTION FOR EXCLUSION OF POST-PROCEDURAL MAJOR ADVERSE CARDIOVASCULAR EVENTS
	-	IMMUNO-MAGNETIC ENRICHMENT FOLLOWED BY MULTI-PARAMETER FLOW CYTOMETRY: A NEW APPROACH TO COUNT CIRCULATING ENDOTHELIAL CELLS
Bonfiglio J.	-	MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA IN HEREDITARY AT DEFICIENT PATIENTS DURING SURGERY
	-	PREGNANT HEREDITARY ANTITHROMBIN DEFICIENT WOMEN REQUIRE A DISTINCT DOSING STRATEGY FOR THE MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA
Bongers T.N.	-	ADAMTS13 LEVELS ARE ASSOCIATED WITH THE RISK OF ARTERIAL THROMBOSIS IN YOUNG SUBJECTS
	-	ADAMTS13 AND VWF IN PEDIATRIC PATIENTS WITH SEVERE MENINGOCOCCAL SEPSIS
Bongrand P.	-	UNIQUE RECIPROCAL MAP KINASE REGULATION IN THROMBIN-INDUCED ENDOTHELIAL PRO-INFLAMMATORY ACTIVATION
Bonito M.C.	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Bonneau M.	-	BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS
	-	DIET MANIPULATION OF ATHEROSCLEROTIC LESIONS IN THE FHD PIG MODEL
Bonnefoy A.	-	INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
Bonnet J.	-	CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Bonnet P.	-	COST-EFFECTIVENESS (CE) OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) VS. RECOMBINANT FVIIA IN PROPHYLAXIS IN HEMOPHILIA PATIENTS WITH INHIBITORS
	-	IMPROVING RECOMBINANT FACTOR VIII (RFVIII) DOSING PRECISION IN THE TREATMENT OF HEMOPHILIA A RESULTS IN POTENTIAL COST SAVINGS
	-	HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING MAJOR ORTHOPEDIC SURGERIES: COST-MINIMIZATION ANALYSIS OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) AND RECOMBINANT FVIIA
Bonno M.	-	LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
	-	PHOSPHOINOSITIDE 3-KINASE-INDUCED CYTOSKELETAL TRANSLOCATION OF PROTEIN KINASE CK2 IN THROMBIN-STIMULATED PLATELETS
Bono F.	-	ANTITHROMBOTIC ACTIVITIES IN PHARMACOLOGICAL MODELS OF A LONG-ACTING REVERSIBLE SYNTHETIC OLIGOSACCHARIDE
	-	SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES
	-	SULFATION OF THE 3-HYDROXYL GROUP OF THE REDUCING UNIT (H) ON ALKYLATED SULFATED PENTASACCHARIDE IS RESPONSIBLE FOR A HIGH AFFINITY FOR ANTITHROMBIN AND LONGER HALF LIFE IN ANIMALS
	-	REVERSIBLE BIOTINYLATED OLIGOSACCHARIDES: A NEW APPROACH FOR A BETTER MANAGEMENT OF THE ANTICOAGULANT THERAPY
	-	IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES
Bonzel T.	-	PLATELET RESPONSIVENESS TOWARDS ANTIPLATELET MEDICATIONS BEFORE AND AFTER CORONARY ANGIOGRAPHY AND PERCUTENOUS CORONARY INTERVENTIONS AS DETERMINED BY WHOLE BLOOD AGGREGOMETRY
Boo D.	-	THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Boomer R.M.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
Boon-Spijker M.	-	THE MARBURG-1 MUTATION REDUCES THE AUTOCATALYTIC ACTIVITY OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP)
Booth N.A.	-	CHAOTIC ADVECTION IN STENOSED ARTERIES
	-	ENHANCEMENT OF SINGLE-CHAIN UROKINASE ACTIVITY BY PLATELET PROTEINS
	-	TAFI ACTIVATION IN MODEL THROMBI
Boquist S.	-	ELEVATED LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION
Bordet J.	-	WALL CLOT GROWTH IN PLASMA: EFFECT OF HIGH DOSES RECOMBINANT FVIIA
	-	ASSESSMENT OF A METHOD BASED ON LUMINESCENCE DETECTION FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
	-	THROMBIN GENERATION TEST IN THE MONITORING OF PROTHROMBIN COMPLEX CONCENTRATES
	-	THROMBIN GENERATING CAPACITY IS HIGHLY DECREASED AND DELAYED IN PATIENTS WITH VON WILLEBRAND DISEASE
Borel Derlon A.	-	IDENTIFICATION OF FACTOR VIII GENE MUTATIONS IN 120 HAEMOPHILIA A PATIENTS: DETECTION OF 26 NOVEL MUTATIONS AND CORRELATION WITH FVIII INHIBITOR DEVELOPMENT
Borel-Derlon A.	-	A NOVEL P.ASP344VAL SUBSTITUTION IN THE FIBRINOGEN GAMMA-CHAIN CAUSES DYSFIBRINOGENEMIA ASSOCIATED WITH THROMBOSIS
	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
Borensztajn K.S.	-	FACTOR (F)XA STIMULATES FIBROPROLIFERATIVE RESPONSES IN FIBROBLASTS VIA PROTEASE ACTIVATED RECEPTOR (PAR)-2 ACTIVATION: IMPLICATIONS FOR TISSUE REMODELING
	-	COAGULATION FACTOR XA INHIBITS CANCER CELL MIGRATION VIA LIMK1-MEDIATED COFILIN INACTIVATION
	-	CHARACTERIZATION OF PAR-MEDIATED SIGNALING CAPACITY OF COAGULATION FACTOR X MUTANTS
Bores C.	-	THROMBIN GENERATION IN BEHET'S DISEASE: RELATIONSHIP WITH THROMBOSIS
Borg J.	-	A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
Borg J.Y.	-	PROTEIN Z LEVEL AND GENE POLYMORPHISMS IN MYOCARDIAL INFARCTION IN THE YOUNG
Borg J.	-	EPIDEMIOLOGY AND ONE-YEAR OUTCOMES IN PATIENTS WITH ACQUIRED HEMOPHILIA A (AH) IN FRANCE: THE SACHA PROSPECTIVE STUDY
Borg J.Y.	-	CLOT STRUCTURE MODIFICATION BY FONDAPARINUX AND CONSEQUENCE ON FIBRINOLYSIS: A NEW MECHANISM OF ANTITHROMBOTIC ACTIVITY
	-	RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT
Borg A.	-	WHICH PATIENTS WITH VENOUS THROMBOSIS DO NOT REQUIRE SCREENING FOR MALIGNANCY? A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH VTE AT MINIMAL RISK OF MALIGNANCY
Borg J.	-	IGG ANTIBODIES WITH HYDROLYTIC ACTIVITY TOWARDS ENDOGENOUS FVIII IN A FRENCH COHORT OF PATIENTS WITH ACQUIRED HEMOPHILIA
Borg A.	-	WHAT DO ELEVATED D-DIMER LEVELS MEAN IN PATIENTS WITHOUT VENOUS THROMBOSIS (VTE)?
Borgel D.	-	THE RGDS SEQUENCE OF THE ANTICOAGULANT PROTEIN C (PC) CONTRIBUTES TO ITS ENDOTHELIAL CELL RECEPTOR (EPCR) BINDING
	-	DECREASED ADAMTS-13 IS ASSOCIATED WITH A POOR PROGNOSIS IN SEPSIS-INDUCED ORGAN FAILURE
	-	ALL PROTEIN S (PS) EPIDERMAL GROWTH FACTOR LIKE DOMAINS (EGFS) SIGNIFICANTLY PARTICIPATE TO ACTIVATED PROTEIN C (APC) COFACTOR ACTIVITY
	-	GENETIC ANALYSIS BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION IN PROTEIN S DEFICIENCY
	-	EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS)
Borgese L.	-	INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
Borggrefe M.	-	HEAT SHOCK PROTEIN 70 (HSP 70) LEVELS AS PROGNOSTIC MARKER OF SEPTIC PATIENTS
Borghetti F.	-	PREFERENCES TOWARDS COAGULATION FACTOR CONCENTRATES USED TO TREAT HEMOPHILIC PATIENTS WITH INHIBITORS: THE PATIENTS', PHYSICIANS' AND PHARMACISTS' PERSPECTIVE
Borghi M.O.	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Borghi M.	-	EFFECTS OF A TOLL-LIKE RECEPTOR ANTAGONIST AND ANTI-ANNEXIN A2 ANTIBODIES ON BINDING AND ACTIVATION OF DECIDUAL CELLS BY ANTIBETA2GLYCOPROTEIN I ANTIBODIES
Borghi M.O.	-	DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
Borgognone A.	-	CAMP-INDUCED INHIBITION OF CA2+ MOBILIZATION IS REVERSED BY TYROSINE PHOSPHORYLATION OF IP3R IN PLATELETS
Bori-Sanz T.	-	COLLAGEN PROMOTES SUSTAINED GPVI SIGNALING IN PLATELETS AND CELL LINES
Borisova T.A.	-	HIGH-AFFINITY GLUTAMATE TRANSPORTERS OF BLOOD PLATELETS AS POTENTIAL PERIPHERAL MARKERS TO ANALYZE GLUTAMATE TRANSPORT ACTIVITY IN BRAIN
Bork K.	-	COAGULATION FACTOR XII MISSENSE MUTATIONS (T309K, T309R) IN HEREDITARY ANGIOEDEMA WITH NORMAL C1 INHIBITOR
Bornaes C.	-	IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
Bornscheuer A.	-	EFFECTS OF FIBRINOGEN LEVELS AND CLOT STRENGTH IN THE PRESENCE OF THROMBOCYTOPENIA
Borow K.	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
Borozanov V.	-	ENDOTHELIAL DYSFUNCTION CORRELATES WITH PLASMA FIBRINOGEN AND HDL CHOLESTEROL IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE
Borrell M.	-	IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
	-	THROMBIN GENERATION ASSAY (TGA) CORRECTION IN VITRO AFTER ADDITION OF THERAPEUTIC RANGE DOSES OF PROTHROMBIN COMPLEX CONCENTRATE (PCC) TO PLASMA SAMPLES WITH INR 5
	-	WHAT IS THE CLINICAL IMPACT OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) DEFICIENCY?
	-	MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
Borris L.C.	-	LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
Borris L.	-	DEVELOPMENT OF A NOVEL ONE STEP LATERAL FLOW DEVISE FOR QUALITATIVE DETECTION OF PROTHROMBIN FRAGMENT F1+2 IN URINE
	-	DETECTION OF HYPERCOAGULABILITY IN HIP ARTHROPLASTY PATIENTS BY REPEATED MEASSUREMENTS OF URINE PROTHROMBIN FRAGMENT 1.2
Borroni L.	-	FALSE UNCOAGULABLE PT-INR RESULTS
Bortolati M.	-	THE MANAGEMENT OF HIGH RISK PREGNANT PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
Bortoletto E.	-	THREE NEW MUTATIONS IN FXII DEFICIENCY
Bos M.H.A.	-	EVOLUTIONARY CONSERVED B-DOMAIN SEQUENCES CONTRIBUTE TO MAINTAINING FACTOR V AS A PROCOFACTOR
Bosari S.	-	ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER
Bosc L.	-	ASPIRIN PREVENTS PLATELET ACTIVATION AFTER CORONARY ARTERY BYPASS SURGERY DESPITE AN INCREASE IN THROMBOXANE A2 SYNTHESIS
Boschetti F.	-	BIOCHEMICAL AND MECHANICAL PROPERTIES OF INTRALUMINAL THROMBUS FROM HUMAN ABDOMINAL AORTIC ANEURYSM
Boschian B. R.	-	HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DIAGNOSTIC ROLE OF POST METHIONINE-LOAD TEST
Bosevski M.	-	ENDOTHELIAL DYSFUNCTION CORRELATES WITH PLASMA FIBRINOGEN AND HDL CHOLESTEROL IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE
Boshkov L.K.	-	ABNORMAL PLATELET FUNCTION IS COMMON IN PEDIATRIC CONGENITAL CARDIAC SURGERY PATIENTS
Bosio E.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Bosman R.J.	-	COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Bosschaerts T.	-	RECURRENT ARTERIAL THROMBOSIS WITH FACTOR V LEIDEN HOMOZYGOCY
Bosson J.L.	-	IS THROMBO-EMBOLIC DISEASE AN HETEROGENEOUS DISEASE ?
Bosson J.	-	RISK FACTORS PREDICTIVE OF CARDIOVASCULAR EVENTS IN AN INCIDENT DIALYSIS COHORT: A ROLE FOR HOMOCYSTEINEMIA AND ITS MTHFR GENOTYPE
	-	CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
Bossuyt P.M.	-	FURTHER VALIDATION AND SIMPLIFICATION OF THE WELLS CLINICAL DECISION RULE IN PULMONARY EMBOLISM
Bottaro E.	-	THROMBOPHILIA IN HIV-INFECTED PATIENTS WITH OSTEONECROSIS: IS THERE A REAL CONNECTION? THE FIRST CASE-CONTROL STUDY
Bottaro F.	-	LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS
	-	PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS
Böttcher A.	-	THE ANTICOAGULANT PROTEINS S AND ANTITHROMBIN DISPLAY REMARKABLE SEX-DEPENDENT CHANGES DURING AGING
Botteman M.F.	-	RECOMBINANT ACTIVATED FACTOR VII VS. ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE AS ON-DEMAND TREATMENT OF JOINT BLEEDS IN HEMOPHILIACS WITH INHIBITORS: A SYSTEMATIC LITERATURE REVIEW
	-	ECONOMIC BENEFITS OF KNEE SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII IN HEMOPHILIA PATIENTS WITH INHIBITORS
Bottenus R.	-	EVALUATION OF VARYING CALCIUM CONCENTRATIONS TO IDENTIFY ANTIB2-GLYCOPROTEIN I LUPUS ANTICOAGULANTS WITH A SILICA CLOTTING TIME METHOD FOR LUPUS ANTICOAGULANT TESTING
	-	THE SYNERGISTIC EFFECTS OF SYNTHETIC PHOSPHOLIPIDS AND RECOMBINANT TISSUE FACTOR IN THE OPTIMIZATION OF A PROTEIN S ASSAY SENSITIVITY
	-	ASSIGNMENT AND VALIDATION OF INR CONTROL AND CALIBRATOR SETS FOR LOCAL CALIBRATION OF INR
	-	SELECTIVE ENHANCEMENT OF PROTEIN S REAGENT SENSITIVITY BY BOVINE GAMMA GLOBULIN
	-	THE IMPACT OF PHOSPHOLIPID COMPOSITION ON THE INTERFERENCE CAUSED BY THE ANTIBIOTIC DAPTOMYCIN IN THROMBOPLASTIN REAGENTS
	-	MULTIFACTORIAL ANALYSIS USING FOUR PHOSPHOLIPIDS TO THOROUGHLY INVESTIGATE CONTROL OF THROMBOPLASTIN PROPERTIES AND SENSITIVITIES
Boubakri C.	-	CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
Bouchard P.	-	PHARMACOKINETIC PROFILES AND PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIP OF A VWF INHIBITORY APTAMER IN THE CYNOMOLGUS MONKEY
	-	ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
	-	PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
Bouchard A.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Boudghene Stambouli B.O.	-	ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS RYTHMATOSUS
Boudreaux M.K.	-	CORRECTION OF HAEMORRHAGIC DISORDERS AFFECTING PLATELETS: GENE THERAPY RESTORES HEMOSTASIS WITHIN A CANINE MODEL FOR GLANZMANN THROMBASTHENIA
Bougie D.W.	-	MONOCLONAL ANTIBODIES THAT MIMIC ANTIBODIES FOUND IN PATIENTS WITH DRUG (QUININE(QN))-INDUCED IMMUNE THROMBOCYTOPENIA (DITP): IMPLICATIONS FOR THE PATHOGENESIS OF DITP
Bouhassira E.E.	-	AN IAP RETROTRANSPOSON IN MOUSE ADAMTS13 GENE GENERATES ADAMTS13 VARIANTS LESS EFFECTIVE IN CLEAVING VWF MULTIMERS
Bouizegarene P.	-	FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Boukour S.	-	PLATELETS AND VIRUSES
	-	PLATELET CHEMOTAXIS INDUCED BY THE SDF-1/CXCR4 CHEMOKINE RECEPTOR SYSTEM
Boulanger E.	-	MESOTHELIAL RAGE ACTIVATION BY AGES ENHANCES VEGF RELEASE AND POTENTIATES CAPILLARY TUBE FORMATION
Boulanger C.	-	HCAN CHANGES IN HEMOSTATIC PARAMETERS EXPLAIN THE INCREASED INCIDENCE OF DVT IN ELDERLY ?
Bouma B.	-	ELEVATED PLASMIN-ALPHA2-ANTIPLASMIN LEVELS IN SYSTEMIC AMYLOIDOSIS INDICATE ACTIVATION OF THE FIBRINOLYTIC SYSTEM
	-	THE USE OF TISSUE-TYPE PLASMINOGEN ACTIVATOR TO DETECT MISFOLDED PROTEINS IN BIOPHARMACEUTICALS
	-	ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS
Bouma B.N.	-	PROTEIN S (PS) CONTAINS ZINC THAT IS ESSENTIAL FOR DIRECT ANTICOAGULANT ACTIVITY
Bouma B.	-	ACTIVATION OF FACTOR XII BY MISFOLDED PROTEIN AGGREGATES; IMPLICATIONS FOR CONTACT ACTIVATION
Bouma B.N.	-	ACTIVATION OF FACTOR XII BY MISFOLDED PROTEIN AGGREGATES; IMPLICATIONS FOR CONTACT ACTIVATION
Bounameaux H.	-	INFLUENCE OF AGE ON THE COST EFFECTIVENESS OF DIAGNOSTIC STRATEGIES FOR SUSPECTED PULMONARY EMBOLISM
	-	A COMPARATIVE ANALYSIS OF THE RESPONSE TO INFLAMMATORY STIMULI OF BLOOD- AND MESENCHYMAL STEM CELLDERIVED ENDOTHELIAL PROGENITOR CELLS
	-	MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
Bourdon L.	-	THE SIGNIFICANCE OF BREAKPOINT DELINEATION IN LARGE DELETIONS IN THE F8 GENE
Bours V.	-	P2X1 RECEPTORS AS NEW REGULATORS OF NEUTROPHIL LIFE SPAN
	-	ATP VIA P2X7 MODULATES THE TLR-DEPENDENT EXPRESSION AND ACTIVITY OF HUMAN NEUTROPHIL INFLAMMASOME
Boutekedjiret T.	-	ASSESSMENT OF THE PREDICTIVE VALUE OF PFA-100 TM OCCLUSION TIME CONCERNING THE HAEMORRHAGIC RISK OF TRANSPARIETAL NEEDLE LIVER BIOPSY IN CHILDREN
Bouton M.C.	-	PROTEASE NEXIN-1 AND THROMBOMODULIN FORM COMPLEXES WITH A HIGHLY POTENT ANTI-THROMBIN ACTIVITY
Boutouyrie P.	-	EFFECT OF HIGH-DOSE APROTININ ON PLATELET FUNCTION AFTER NORMOTHERMIC CARDIOPULMONARY BYPASS IN CHILDREN CARDIAC SURGERY
	-	LACK OF ENDOTHELIAL DYSFUNCTION IN THROMBOANGIITIS OBLITERANS
Bouziane A.	-	PLATELET MICROPARTICLES ARE A PREDICTIVE FACTOR OF OVERALL SURVIVAL IN PATIENTS WITH PROSTATE CANCER
	-	ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA?
	-	PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
Boval B.	-	BIOLOGICAL INHIBITION OF PLATELET PROSTAGLANDIN PATHWAY IS NOT MAINTAINED BY LOW DOSE ASPIRIN THROUGHOUT 24 HOURS IN TYPE 2 DIABETIC PATIENTS
	-	A NEW ANTITHROMBOTIC STRATEGY FOR PATIENTS WITH LONG TERM MECHANICAL CIRCULATORY SUPPORT (MCS)
	-	CYP2C19*2 POLYMORPHISM INFLUENCES PLATELET FUNCTIONNALITY IN RESPONSE TO CLOPIDROGEL TREATMENT
	-	ABNORMALITIES IN THE SEROTONIN METABOLISM: A PATHOGENIC HYPOTHESIS FOR CENTRAL RETINAL VEIN OCCLUSION (CRVO)
	-	HETEROGENEITY OF ESSENTIAL THROMBOCYTHEMIA: VARIABLE EXPRESSION OF THE V617F JAK2 MUTATION AND THE PLATELET CD36 LEVEL. NO ASSOCIATION WITH THROMBOTIC MANIFESTATIONS
	-	FUNCTIONAL VARIABILITY OF PLATELET RESPONSE TO CLOPIDOGREL CORRELATES WITH P2Y12 RECEPTOR OCCUPANCY
Bovill E.G.	-	LINKAGE ANALYSIS FOR NORMAL PROTEIN C LEVELS IN A PROTEIN C-DEFICIENT FAMILY
Bovina V.	-	NO INCREASED SIGNS OF ATHEROSCLEROTIC ALTERATIONS IN CARRIERS OF INHERITED THROMBOPHILIA WITH OR WITHOUT PREVIOUS VENOUS THROMBOSIS
Bowley S.R.	-	FIBRINOGEN VARIANT BD432A: NEW INSIGHTS ON THE ROLE OF "B:b" INTERACTIONS IN FIBRIN POLYMERIZATION
	-	DO B:b INTERACTIONS HAVE A ROLE IN FIBRIN POLYMERIZATION?
Bowman M.	-	THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
	-	THE PREVALENCE OF SYMPTOMATIC VON WILLEBRAND DISEASE (VWD) IN PRIMARY CARE PRACTICE
	-	DIAGNOSTIC EFFICACY OF SYSTEMATIC INVESTIGATION OF NON-VON WILLEBRAND BLEEDERS: RESULTS OF A PROSPECTIVE STUDY
Bowyer A.	-	THROMBIN GENERATION TO MONITOR INHIBITOR BYPASS AGENTS REQUIRES LOW CONCENTRATIONS OF TISSUE FACTOR (TF)
Bowyer A.E.	-	COMPARISON OF THROMBIN GENERATION WITH MODIFIED THROMBOELASTOMETRY IN HAEMOPHILIA A
	-	FACTOR VIII ASSAY DISCREPANCY IN TYPE 2N VWD IS REAGENT DEPENDANT
Bowyer A.	-	SIGNIFICANT VARIATION IN THROMBIN GENERATION POTENTIAL IN "ADEQUATELY" ANTICOAGULATED PATIENTS
Bowyer A.E.	-	THE CHROMOGENIC FVIII:C ASSAY IS A SUITABLE ALTERNATIVE TO THE TWO-STAGE ASSAY IN DETECTION OF MILD HAEMOPHILIA A PATIENTS WITH ONE-STAGE, TWO-STAGE DISCREPANCY
Boyd S.R.	-	IMPAIRED ANGIOGENESIS AND ENHANCED INTRACRANIAL VASCULAR APOPTOSIS IN A MURINE MODEL OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAITP)
Boyer-Neuman C.	-	TREATMENT OF VTE DURING PREGANCY WITH A ONCE-DAILY REGIMEN OF LMWH
Boylan B.	-	HUMAN PLATELETS CIRCULATING IN MICE: APPLICATIONS FOR INTERROGATING PLATELET FUNCTION AND SURVIVAL, THE EFFICACY OF ANTI-PLATELET THERAPEUTICS, AND THE MOLECULAR BASIS OF PLATELET IMMUNOLOGICAL DISORDERS
Boyle D.	-	PHARMACOKINETICS (PK) OF SUBCUTANEOUS FONDAPARINUX 1.5 MG IN PATIENTS WITH MODERATE RENAL IMPAIRMENT (MRI)
Bozek M.	-	CONTRIBUTION OF ALPHA-FIBRINOGEN A312 ALLELE TO DECREASED THROMBIN GENERATION IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING SURGERY
Bozic M.	-	OVERALL HAEMOSTASIS POTENTIAL IN PATIENTS WITH VENOUS THROMBOSIS BEFORE, DURING AND AFTER ANTICOAGULANT TREATMENT
	-	MATRIX METALLOPROTEINASE-3, TISSUE INHIBITOR OF METALLOPROTEINASES-1 AND WARFARIN TREATMENT
Bo[zcaron]i[ccaron] M.	-	VENOUS THROMBOEMBOLISM ASSOCIATED POLYMORPHISMS IN SLOVENE POPULATION
Bozic M.	-	IS BIOLOGICAL VARIATION OF PLATELET FUNCTION TESTS TOO HIGH FOR RELIABLE DETECTION OF ASPIRIN RESISTANCE?
Bozzi V.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Bozzini C.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Bracey A.	-	PLATELET AND MONOCYTE ACTIVATION IN PATIENTS UNDERGOING CIRCULATORY SUPPORT WITH LEFT VENTRICULAR ASSIST DEVICES (LVAD)
Bradford H.	-	DOMAIN 5 PEPTIDES OF HIGH MOLECULAR MASS KININOGEN UNDERGO CONFORMATIONAL CHANGES INDUCED BY ZINC
Bradstreet C.	-	RECURRENT ARTERIAL THROMBOSIS WITH FACTOR V LEIDEN HOMOZYGOCY
Braekkan S.	-	FAMILY HISTORY OF MYOCARDIAL INFARCTION (MI) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
	-	MEAN PLATELET VOLUME (MPV) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
Braga K.G.	-	PREVALENCE OF POLYMORPHISMS IN EXONS 6 E 7 OF ABO LOCUS AND THEIR ASSOCIATION WITH VENOUS THROMBOSIS IN YOUNG BRAZILIAN PATIENTS
Braga J.	-	SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
Braimi M.	-	SECONDARY THROMBOPHYLAXIS USING ANTIPLATELET AGENTS AND LONG TERM MONITORING AFTER 1ST UNPROVOKED EPISODE OF VENOUS THROMBOEMBOLISM
Brainovic J.	-	EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
Brakebusch C.	-	RHOA IS ESSENTIAL FOR MEGAKARYOCYTE SURVIVAL IN VIVO
	-	RAC1 IS AN EFFECTOR OF THE GPVI SIGNALING CASCADE IN PLATELETS
	-	DOUBLE-DEFICIENCY OF RAC1 AND CDC42 SEVERELY AFFECTS PLATELET PRODUCTION AND FUNCTION
Brambilla M.	-	EVALUATION OF THE EFFECT OF TWO DIFFERENT DOSES OF ASPIRIN IN PATIENTS UNDERGOING CABG
	-	DIFFERENT PATTERN OF TF EXPRESSION IN PLATELETS, LEUKOCYTES AND AGGREGATES OF CAD PATIENTS
Brancazio L.	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: MATERNAL THROMBOPHILIA
Brand B.	-	DISTINCTIVE THROMBOELASTOGRAPHIC FINDINGS (TEG-PM IN RESPONSE TO ADP) IN A FAMILY WITH BERNARD SOULIER SYNDROME
Brandao L.	-	NEONATAL RENAL VEIN THROMBOSIS - 15 YEARS OF LITERATURE
Brandao L.R.	-	THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
	-	DOSING EFFICACY AND SAFETY OF UNFRACTIONATED HEPARIN IN INFANTS WITH THROMBOTIC COMPLICATIONS
	-	PLATELET FUNCTION THROMBOELASTOGRAPHY (PFT)
	-	EVALUATION OF THROMBOLYTIC THERAPY WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) FOR PROSTHETIC VALVE THROMBOSIS IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE
Brandao L.	-	THE EFFICACY AND SAFETY OF ANTITHROMBIN CONCENTRATE IN CHILDREN RECEIVING HEPARIN INFUSIONS
	-	COMPARISON OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR VENOUS THROMBI AND ARTERIAL THROMBI IN CHILDREN
	-	THE EFFICACY AND SAFETY OF FRESH FROZEN PLASMA (FFP) AND SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR TREATMENT OF INTRAVASCULAR THROMBOSIS IN INFANTS
Brandao L.R.	-	CLINICAL CHARACTERISTICS OF PULMONARY EMBOLISM IN CHILDHOOD- EXPERIENCE FROM A SINGLE CENTRE
Brandao L.	-	DO WE NEED DIFFERENT STANDARD CURVES FOR MEASURING DIFFERENT LOW MOLECULAR WEIGHT HEPARINS?
	-	HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
	-	OUTCOMES OF THROMBOLYSIS FOR REPEATED COURSES OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR INTRAVASCULAR THROMBOSIS IN CHILDREN
Brandenburg V.	-	Circulating inactive human Matrix Gla Protein (ucMGP) as a biomarker for cardiovascular disease
Brandin M.	-	ANALYZE OF THE CO-PURIFIED PROTEINS WITH A HIGHLY PURIFIED PLASMA-DERIVED FACTOR VIII: FVIII-SD-35-15
Brandini R.	-	INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
Brandjes D.P.M.	-	ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION
Brandl R.	-	EFFECT OF ANTI-PLATELET DRUGS ON PLATELET AGGREGATION AND THROMBUS FORMATION INDUCED BY HUMAN ATHEROSCLEROTIC PLAQUES
Brands M.	-	PLATELET DENSE GRANULE SECRETION ACCELERATES THE DEVELOPMENT OF ARTERIOSCLEROSIS AFTER VASCULAR INJURY
Brandt J.T.	-	GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
	-	EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
Brandt M.	-	THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY
Brandt J.T.	-	GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
	-	INDIVIDUAL AND COMBINED EFFECTS OF ASPIRIN AND THIENOPYRIDINES IN ATTENUATION OF PLATELET AGGREGATION INDUCED BY COLLAGEN AND OTHER AGONISTS
Branicka A.	-	CONTRIBUTION OF ALPHA-FIBRINOGEN A312 ALLELE TO DECREASED THROMBIN GENERATION IN PATIENTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING SURGERY
	-	NO DECREASE IN THROMBIN FORMATION AT THE SITE OF MICROVASCULAR INJURY IN PATIENTS TREATED WITH CLOPIDOGREL
Brass L.	-	LOSS OF SEMA4D SIGNALING BETWEEN PLATELETS DESTABILIZES ARTERIAL THROMBI AND REDUCES MYOCARDIAL INFARCT SIZE
Brass L.F.	-	IDENTIFICATION OF NOVEL PLATELET MEMBRANE PROTEINS USING MULTI-DIMENSIONAL PROTEIN IDENTIFICATION TECHNOLOGY
	-	THE TIGHT JUNCTION PROTEIN ESAM IS RECRUITED TO PLATELET-PLATELET CONTACTS AND FORMS SIGNALING COMPLEXES THAT AFFECT THROMBUS GROWTH AND STABILITY
Brass L.	-	JUNCTIONAL ADHESION MOLECULE A (JAM-A) NEGATIVELY REGULATES AGONIST-INDUCED PLATELET ACTIVATION
Brass L.F.	-	CONTACT-DEPENDENT INTERACTIONS THAT AFFECT THROMBUS GROWTH AND STABILITY
Brasser M.	-	HANDHELD COMPUTERS: AN EFFECTIVE SYSTEM TO RECORD HOME-THERAPY DATA OF PATIENTS WITH HAEMOPHILIA
Brasseur B.	-	IMPACT OF PROPHYLACTIC ADMINISTRATION OF FFP ON HYPOFIBRINOGENEMIA IN PAEDIATRIC PATIENTS TREATED WITH L-ASPARAGINASE FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
Brauer M.	-	THE VALUE OF ROTEM THROMBOLELASTOMETRY TO DETECT DISTURBED HAEMOSTASIS AND BLEEDING RISK IN ON-PUMP CARDIAC SURGERY
Braun A.	-	AN EF-HAND MUTATION IN STIM1 CAUSES PREMATURE PLATELET ACTIVATION AND BLEEDING IN MICE
Braun O.	-	GREATER PLATELET P2Y12 INHIBITION BY PRASUGREL COMPARED TO HIGH DOSE CLOPIDOGREL ASSESSED BY VASP PHOSPHORYLATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
	-	GREATER INHIBITION OF PLATELET ACTIVATION AND PLATELET-MONOCYTE COMPLEX FORMATION BY PRASUGREL COMPARED TO CLOPIDOGREL IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Braun A.	-	UNALTERED CA2+ HOMEOSTASIS AND AGONIST-INDUCED ACTIVATION IN PLATELETS LACKING TRANSIENT RECEPTOR POTENTIAL (TRP) C1
Braunwald E.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Bray P.F.	-	PREVALENCE OF "ASPIRIN RESISTANCE" IN CHILDREN
Brazzelli V.	-	CARDIOVASCULAR DISEASE, HYPERHOMOCYSTEINEMIA AND ATHEROTHROMBOTIC RISK FACTORS IN PSORIATIC PATIENTS
Bredoux R.	-	CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS
Breindahl M.	-	DEVELOPMENT OF A NOVEL ONE STEP LATERAL FLOW DEVISE FOR QUALITATIVE DETECTION OF PROTHROMBIN FRAGMENT F1+2 IN URINE
Breindal M.	-	DETECTION OF HYPERCOAGULABILITY IN HIP ARTHROPLASTY PATIENTS BY REPEATED MEASSUREMENTS OF URINE PROTHROMBIN FRAGMENT 1.2
Breinholt V.M.	-	IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
Breitenstein S.	-	COMPARISON OF THREE METHODOLOGIES TO ASSAY D-DIMER LEVELS IN SURGICAL PATIENTS: D DIMER ON MINIVIDAS VS. TINA-QUANT ON MODULAR P VS. TINA-QUANT ON BEHRING COAGULATION SYSTEM - A CALL FOR STANDARDISATION IN D-DIMER TESTING
Brejcha M.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Breña S.	-	DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN ATTENUATES PLATELET REACTIVITY AND PROTHROMBOTIC EFFECT OF ERYTHROCYTES IN PATIENTS AFTER CAROTID STENTING
Brennecke S.	-	IDIOPATHIC FETAL GROWTH RESTRICTION (FGR) IS ASSOCIATED WITH DECREASED ANTICOAGULANT PROTEOGLYCAN DECORIN EXPRESSION IN HUMAN PLACENTA
Brenner B.	-	ADAMTS-13 ACTIVITY, ANTIGEN AND INHIBITOR ANTIBODIES IN TTP PATIENTS A SINGLE CENTER EXPERIENCE
	-	HEPARANASE INDUCES TFPI EXPRESSION AND EXTRACELLULAR ACCUMULATION IN ENDOTHELIAL AND TUMOR CELLS
	-	COAGULATION PARAMETERS IN AMNIOTIC FLUID DURING HUMAN PREGNANCY ROLE OF TF AND TFPI
	-	MICROPARTICLES' INDUCE PRO-COAGULANT AND APOPTOTIC EFFECTS ON ENDOTHELIAL CELLS
	-	EFFECT OF FIBRIN MATRICES ON INCREASED PROLIFERATION AND SPREADING OF EARLY TERM TROPHOBLASTS AND PLACENTAL VILLI. MODULATION OF COAGULATION AND ANGIOGENESIS FUNCTIONS
	-	THE ROLE OF MICROPARTICLES IN GESTATIONAL VASCULAR COMPLICATIONS
Brettler D.B.	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Breuss J.	-	REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
Breuss J.M.	-	ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
Briassoulis G.	-	LONGITUDINAL COURSE AND CLINICAL SIGNIFICANCE OF TGF-B1, SL- AND SE-SELECTINS AND SICAM-1 LEVELS DURING SEVERE ACUTE STRESS IN CHILDREN
Bridey F.	-	A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HAEMOPHILIA B
	-	FINAL RESULTS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE PHARMACOKINETICS, EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15 NANOMETER-FILTERED PLASMA-DERIVED FACTOR VIII
	-	EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
Bridson G.	-	PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
Brighton T.	-	CARDIOVASCULAR RISK FACTORS AND VENOUS THROMBOEMBOLISM: A META-ANALYSIS
Brighton T.A.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Brigulla M.	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
Brill A.	-	PRO- AND ANTI-ANGIOGENIC CYTOKINES ARE CONDITIONALLY AND SELECTIVELY RELEASED FROM ALPHA-GRANULES UPON PLATELET STIMULATION
Brill G.E.	-	RED LASER RADIATION INCREASES PLATELET RESPONSE TO ADP
Brill A.	-	THE ROLE OF PLATELET MICROPARTICLES IN ANGIOGENESIS AND TUMOR BIOLOGY
Brioschi M.	-	TISSUE FACTOR INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 REQUIRES INTACT CAVEOLIN-ENRICHED MEMBRANE MICRODOMAINS IN HUMAN ENDOTHELIAL CELLS
	-	PROTEOME OF ENDOTHELIAL CELL-DERIVED PROCOAGULANT MICROPARTICLES
	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
Brisack K.	-	REMOVAL OF PORCINE PARVOVIRUS SPIKED INTO SAMPLES OF HUMAN RECOMBINANT FACTOR VIII
Brito F.C.F.	-	NEW THIENYLACYLHYDRAZONE DERIVATIVES AS CYCLIC NUCLEOTIDES MODULATORS AND PLATELET AGGREGATION INHIBITORS
Brittenden J.	-	PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIC EVENTS IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY
	-	ARTERIAL STIFFNESS, ENDOTHELIAL FUNCTION AND THE RISK OF ISCHAEMIC STROKE
	-	PLATELET ACTIVATION INCREASES WITH THE SEVERITY OF PERIPHERAL ARTERIAL DISEASE: IMPLICATIONS FOR CLINICAL MANAGEMENT
Britto M.	-	MOLECULAR AND CELLULAR DYNAMICS OF MOESIN IN VASCULAR CELLS VIA MECHANO-TRANSDUCTION
	-	THE MECHANO-REGULATION OF LASP-1 IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE
Brocal I.	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) GENE POLYMORPHISM AND RISK FOR VENOUS THROMBOSIS DISEASE (VTD)
Brock J.	-	RESTORING INITIAL THROMBIN GENERATION DOES NOT NORMALIZE CUTANEOUS WOUND HEALING IN HEMOPHILIA B
	-	GLYCOSYLATION OF THE ACTIVATION PEPTIDE OF FACTOR IX DETERMINES PLASMA HALF-LIFE
Brodde M.F.	-	THROMBOSPONDIN-1 INHIBITS PLATELET AND MONOCYTE ACTIVATION BY HOCL-OXIDISED PROTEINS
Broderick J.P.	-	LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL
Brodin E.	-	ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PLASMA FROM PATIENTS WITH AMI DURING ANTITHROMBOTIC TREATMENT
Brodmann D.	-	PHARMACOKINETICS OF DALTEPARIN IN PROPHYLACTIC DOSAGE IN PATIENTS WITH IMPAIRED RENAL FUNCTION
Brohée D.	-	USE OF SOLUBLE FIBRIN MONOMER (SFM) WITH DDIMER (DDI) AND THE ISTH SCORE MAY AID IN DIAGNOSIS OF DIC
Broijersen A.	-	DOES ANGIOTENSIN II HAVE PROINFLAMMATORY OR PROTHROMBOTIC EFFECTS?
Brojer E.	-	BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
Bromirski J.	-	IMPORTANCE OF FIBRIN BINDING FOR THERAPEUTIC EFFICACY OF DIRECT THROMBOLYTICS
Brookhart G.L.	-	RECOMBINANT HUMAN PLASMIN PRODUCED IN LEMNA MINOR
Brooks S.	-	THROMBIN GENERATION & ROTEM TESTS IN PREGNANCY: POTENTIAL FOR MONITORING ADEQUACY OF LOW MOLECULAR WEIGHT HEPARIN ADMINISTRATION
Brophy M.T.	-	SF-12 PHYSICAL COMPONENT SCORE IS AN INDEPENDENT PREDICTOR OF MAJOR HEMORRHAGE IN A COHORT OF ELDERLY PATIENTS ANTICOAGULATED FOR ATRIAL FIBRILLATION
Brophy D.F.	-	EFFECT OF RECOMBINANT FACTOR VIIA VARIANT (NN1731) ON PLATELET FUNCTION, CLOT STRUCTURE AND FORCE ONSET TIME IN BLOOD FROM HEALTHY VOLUNTEERS AND HEMOPHILIA PATIENTS
Brosnan J.F.	-	SEX STEROIDS USED IN HORMONE TREATMENT ALTER COAGULATION GENE EXPRESSION IN CULTURED HUVEC
	-	DIFFERENTIAL EFFECTS OF TRANSDERMAL AND ORAL ESTRADIOL/NORETHISTERONE ACETATE HORMONE THERAPIES ON COAGULATION AND FIBRINOLYTIC MARKERS
Brosnan N.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Brosstad F.R.	-	ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
Brosstad F.	-	HUMAN PLATELETS AND MEGAKARYOCYTES CONTAIN FACTOR X mRNA, DETECTED WITH REAL-TIME QUANTITATIVE RT-PCR
Brotman D.J.	-	NOVEL RISK FACTORS FOR DEEP VEIN THROMBOSIS IN HOSPITALIZED PATIENTS
Brouland J.	-	DIET MANIPULATION OF ATHEROSCLEROTIC LESIONS IN THE FHD PIG MODEL
	-	BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS
Brouns R.	-	GENERATION OF CARBOXYPEPTIDASE U (TAFIA) IN ISCHEMIC STROKE PATIENTS RECEIVING THROMBOLYTIC THERAPY
Brouwer J.P.	-	INCREASED TAFI LEVELS AND THE RISK OF THROMBOEMBOLISM
Brouwers M.C.G.J.	-	MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
Browett P.	-	CHARACTERISATION OF RZPI PRODUCED IN ESCHERICHIA COLI
Brown K.	-	TISSUE PLASMINOGEN ACTIVATOR AND PLASMINOGEN DOMAINS REGULATING THE POTENCY OF THERAPEUTIC THROMBOLYSIS
Brown A.	-	ECONOMIC EVALUATION OF POINT-OF-CARE MONITORING DEVICES FOR LONG-TERM ORAL ANTICOAGULATION THERAPY
Brown C.	-	THE INFLUENCE OF INTRON 1 SEQUENCE VARIATIONS IN MUTATION- NEGATIVE TYPE 1 VON WILLEBRAND DISEASE PATIENTS
Brown A.	-	DO POINT OF CARE DEVICES IMPROVE OUTCOMES IN PATIENTS ON ORAL ANTICOAGULANT THERAPY
Brown C.	-	INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
Brown D.L.	-	FAILURE OF IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA B PATIENTS WITH C, T 6460 NONSENSE MUTATION
	-	SENSITIVITY TO ACTIVATED PROTEIN C (APC) IS INCREASED DURING THE SECRETORY PHASE OF THE MENSTRUAL CYCLE
Brown L.A.	-	MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
Brown C.	-	MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
Brown S.	-	CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Brownlow S.L.	-	A ROLE FOR TRPV1 IN THE ACTIVATION OF HUMAN PLATELETS
Brubaker A.	-	DIFFERENCES IN THE OLIGOSACCHARIDE COMPOSITION OF GENERIC VERSIONS OF ENOXAPARIN AND DALTEPARIN
	-	DIFFERENTIATION OF LOW MOLECULAR WEIGHT HEPARINS AS STUDIED BY MOLECULAR WEIGHT PROFILE AND HEPARINASE-I DEPOLYMERIZATION: PHARMACOLOGIC IMPLICATIONS
Brückmann M.	-	HEAT SHOCK PROTEIN 70 (HSP 70) LEVELS AS PROGNOSTIC MARKER OF SEPTIC PATIENTS
Bruel A.	-	THE KOGEOGPK PEPTIDE FROM TYPE III COLLAGEN INHIBITS BREAST ADENOCARCINOMA CELL ADHESION TO TYPE III COLLAGEN AND HUVEC MATRIX IN WHOLE BLOOD AND UNDER FLOW CONDITIONS
	-	EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
Bruetman J.	-	PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS
Brugge J.M.	-	CATHEPSIN G IS NOT A SPECIFIC AGONIST FOR PROTEASE ACTIVATED RECEPTORS IN PLATELETS
Bruggemann L.W.	-	HYPERGLYCEMIA ACCELERATES ARTERIAL THROMBUS FORMATION AND ATTENUATES THE ANTITHROMBOTIC RESPONSE TO ENDOTOXIN IN MICE
Brügger-Andersen T.	-	NT-PROBNP, AND NOT TF, FM, PAPP-A, MPO OR CD40 LIGAND, PREDICTS RECURRENT TROPONIN-T POSITIVE CARDIAC EVENTS FOLLOWING AN ACUTE MYOCARDIAL INFARCTION
Brugger-Andersen T.	-	ACTIVATED FACTOR XII TYPE A INDEPENDENTLY PREDICTS 12 MONTH MORTALITY IN CHEST PAIN PATIENTS
Brummel-Ziedins K.	-	ASSOCIATION BETWEEN ASPIRIN RESISTANCE AND INCREASED THROMBIN GENERATION AT THE SITE OF MICROVASCULAR INJURY: THE EFFECT OF SIMVASTATIN
	-	THROMBIN GENERATION PROFILES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE: A COMPUTATIONAL ANALYSIS
Brun N.C.	-	LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL
Brunaud C.	-	FUNCTIONAL ANALYSIS OF HUMAN PLATELETS IN NOD/SCID MICE
Brunet P.	-	THE UREMIC SOLUTE INDOXYL SULFATE INDUCES OXIDATIVE STRESS IN ENDOTHELIAL CELLS
Brunet D.	-	RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT
Brunette A.	-	INFLUENCE OF PHOSPHOLIPID SURFACE AND CONCENTRATION IN THROMBOGRAPHY
Brunetti F.	-	SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
Bruneval P.	-	BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA
Bruni F.	-	INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
Brunner P.	-	UROKINASE (UPA) INDUCES ENDOTHELIAL CELL SURVIVAL VIA THE X-LINKED INHIBITOR OF APOPTOSIS PROTEIN (XIAP)
Bruno G.	-	HOME CLINICAL ASSISTANCE: SICILIAN SURVEY ON THE HCA SUPPORT FOR THE MANAGEMENT OF THE PROPHYLAXIS IN PAEDIATRIC HAEMOPHILIAC PATIENTS
Bruns C.	-	CLINICAL EXPERIANCE WITH A RAPID SCREENING TEST FOR HEPARIN/PF4-ANTIBODIES
Bruny I.	-	AUTOMATED QUANTIFICATION OF VON WILLEBRAND FACTOR ACTIVITY WITH HEMOSIL ON THE CA 7000 COAGULOMETER: A VALIDATION STUDY
Bruwer A.	-	CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Bryan S.	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
Bryant A.	-	COMBINING 4T'S PRE-TEST CLINICAL SCORE AND ID-PAGIA HEPARIN/PF4 TEST TO EXCLUDE HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
Bryant J.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Bryckaert M.	-	INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
	-	PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION
Brzewski M.	-	HAEMOTHORAX IN A BOY WITH SEVERE HAEMOPHILIA AND FACTOR VIII INHIBITOR
	-	EVALUATION OF EFFICACY OF RADIOACTIVE SYNOVECTOMY IN RECURRENT JOINT BLEEDING IN HAEMOPHILIA
Brzezinska-Kolarz B.	-	THROMBIN GENERATION IN CHRONICALLY ANTICOAGULATED PATIENTS
Buchetti B.	-	LDL ARE OXIDATIVELY MODIFIED BY PLATELETS VIA GP91PHOX
Buchholz H.	-	POINT OF CARE INR MONITORING IN CHILDREN WITH VENTRICULAR ASSIST DEVICES
Büchi L.	-	PERSISTENT PLATELET MICROPARTICLE FORMATION IN THE PRESENCE OF BLOCKERS OF GP IBALPHA, GPIIB/IIIA, CALCIUM CHELATORS AND ADP SCAVENGERS UNDER HIGH SHEAR STRESS
Buchmueller K.L.	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
Buck S.	-	INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Buckland R.J.	-	P2Y12 BLOCKADE BY PRASUGREL ACTIVE METABOLITE YIELDS COMPLETE INHIBITION OF P2Y12-MEDIATED AMPLIFICATION OF PLATELET RESPONSES
Buckley S.	-	HEPATIC TARGETING OF ADENOVIRUS MEDIATED BY COAGULATION FACTOR X
Buckman B.O.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Buczko W.	-	N-METHYLNICOTINAMIDE INHIBITS ARTERIAL THROMBOSIS IN HYPERTENSIVE RATS
	-	PLASMIN SYSTEM REGULATION IN OVA-SENSITIZED RAT MODEL OF ASTHMA
	-	THE PROTHROMBOTIC AND HYPERTENSIVE EFFECTS OF ANGIOTENSIN(1-9) IN RATS MAY BE MEDIATED BY ANGIOTENSIN II
Buczma A.	-	WHAT DOES HIGH PREVALANCE OF FACTOR V LEIDEN MUTATION IN POLISH SEVERE HAEMOPHILIACS MEAN?
	-	BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
	-	"IMPACT R" - A NEW SCREENING TOOL FOR VON WILLEBRAND DISEASE?
Budde U.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	CHARACTERIZATION OF COMMERCIALLY AVAILABLE VWF-CONTAINING FVIII CONCENTRATES BY VWF MULTIMER ANALYSIS
	-	A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
Budnik I.A.	-	RED LASER RADIATION INCREASES PLATELET RESPONSE TO ADP
Buechner T.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Buelens K.	-	THE BIOCHEMICAL IMPORTANCE OF GLYCOSYLATION IN THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR
Buesing R.	-	RELATIVE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARINS IN HUMAN AND FELINE BLOOD PLASMA. POTENTIAL THERAPEUTIC IMPLICATIONS
Buff M.	-	DESIGN AND IN VITRO CHARACTERIZATION OF A PHOTODYNAMIC ANTICOAGULANT
Buffie C.	-	RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
	-	ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
Bufi M.	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
Bugert P.	-	THE RISK FOR THROMBOEMBOLIC DISEASE IN LUPUS ANTICOAGULANT PATIENTS DUE TO PATHWAYS INVOLVING P-SELECTIN AND CD154
	-	DOPAMINE IS A COACTIVATOR FOR PLATELET ADHESION TO COLLAGEN AND ACTS VIA D2-LIKE RECEPTORS
Bugge T.H.	-	FIBRIN AND FIBRINOLYSIS IN INFECTION AND HOST DEFENSE
Bühler B.	-	EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
Buil A.	-	GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
	-	MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT
Buitrago Murcia L.	-	LDL-INDUCED PLATELET ACTIVATION INVOLVES SPECIFIC DOMAINS IN APOB100
Bukys M.A.	-	ISOLATION AND CHARACTERIZATION OF AN ANTI-FACTOR VIII ANTIBODY FROM A PATIENT WITH ACQUIRED HEMOPHILIA
	-	THE INTERACTION OF PROTHROMBIN WITH THE MEMBRANE SURFACE IS A PREREQUISITE FOR OPTIMUM EXPRESSION OF FACTOR VA COFACTOR ACTIVITY WITHIN PROTHROMBINASE
	-	THE ROLE OF THE ACIDIC COOH-TERMINAL REGION OF FACTOR VA HEAVY CHAIN DURING ACTIVATION OF PROTHROMBIN BY PROTHROMBINASE
	-	ALLOSTERIC REGULATION OF PROTHROMBIN ACTIVATION BY FACTOR VA
	-	IDENTIFICATION OF A BINDING SITE FOR FACTOR XA ON THE LIGHT CHAIN OF FACTOR VA
	-	CHARACTERIZATION OF A PENTAPEPTIDE THAT MODULATES PROTHROMBINASE ACTIVITY
Bulabois B.	-	TAFI ACTIVITY LEVELS AND RECURRENT VENOUS THROMBOEMBOLIC DISEASE
Bulanov A.Y.	-	HEMODILUTION CAUSES HYPERCOAGULABILITY
Bulikova A.	-	EFFECT OF THE FIRST DOSE SIZE OF RECOMBINANT FACTOR VIIa ON TREATMENT EFFICACY OF FREQUENT JOINT BLEEDS IN PATIENT WITH HAEMOPHILIA A AND INHIBITOR
	-	ACQUIRED FACTOR VIII INHIBITOR: REPORT FROM THE REGIONAL HAEMOPHILIA CENTRE
Buliková A.	-	THE DIFFERENT SENSITIVITY OF TWO APTT REAGENTS FOR DIAGNOSIS OF LUPUS ANTICOANGULANT
Buller H.R.	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
Büller H.R.	-	DABIGATRAN ETEXILATE IS EFFECTIVE AND SAFE FOR THE EXTENDED PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP REPLACEMENT
Buller H.R.	-	SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM. THE TROUSSEAU INVESTIGATORS
Büller H.R.	-	PREVENTION OF TRAVELLERS' THROMBOSIS: A COMPARISON OF THREE INTERVENTIONS THAT PROMOTE VENOUS OUTFLOW
Buller H.R.	-	CANCER AND THROMBOSIS: FROM MOLECULAR MECHANISMS TO CLINICAL PRESENTATIONS
Büller H.R.	-	THROMBOPHILIC RISK FACTORS FOR FIRST VENOUS THROMBOEMBOLISM, RECURRENCE AND ITS IMPLICATIONS: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
Buller H.R.	-	HIGH D-DIMER LEVEL INCREASES THE LIKELIHOOD OF PULMONARY EMBOLISM IN A HIGH-RISK POPULATION
Büller H.R.	-	MAJOR CHANGES IN THE DIAGNOSTIC WORK-UP OF PULMONARY EMBOLISM BETWEEN 1999 AND 2004
Buller H.R.	-	SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY
	-	DETERMINANTS OF THE ENDOGENOUS THROMBIN POTENTIAL IN A DUTCH THROMBOPHILIC FAMILY
Büller H.R.	-	HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
Buller H.R.	-	LATE BREAKING CLINICAL TRIAL: A DOSE FINDING STUDY OF THE ORAL DIRECT FACTOR XA INHIBITOR APIXABAN IN THE TREATMENT OF PATIENTS WITH ACUTE SYMPTOMATIC DEEP VEIN THROMBOSIS - THE BOTTICELLI INVESTIGATORS
Büller H.R.	-	LONG DISTANCE TRAVEL AND RISK OF VENOUS THROMBOSIS: EFFECT OF PROCOAGULANT FACTOR LEVELS
Buller H.R.	-	THYROID DISEASES AND THE COAGULATION SYSTEM: A SYSTEMATIC REVIEW
Büller H.R.	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY
Buller H.R.	-	FURTHER VALIDATION AND SIMPLIFICATION OF THE WELLS CLINICAL DECISION RULE IN PULMONARY EMBOLISM
Buller H.	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) AND CANCER SURVIVAL. A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN PATIENTS WITH AND WITHOUT VTE
Büller H.R.	-	THE ABSOLUTE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL: EFFECT OF RISK FACTORS AND BEHAVIOUR DURING FLIGHTS
Büller H.	-	ONCE-WEEKLY SUBCUTANEOUS IDRAPARINUX (ANTI-XA) VERSUS ORAL VITAMIN K ANTAGONIST THERAPY FOR THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
Buller H.	-	A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Büller H.R.	-	DOES THE PRESENCE OF MULTIPLE INHERITED THROMBOPHILIC DEFECTS EXPLAIN THE INCREASED RISK OF ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH PRIOR VENOUS THROMBOEMBOLISM?
Büller H.	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY
Büller H.R.	-	TREATMENT OF PROXIMAL DEEP VEIN THROMBOSIS (DVT): RIVAROXABAN ONCE OR TWICE DAILY HAD SIMILAR EFFICACY AND SAFETY TO STANDARD THERAPY IN PHASE II STUDIES
	-	TRENDS IN THE DIAGNOSTIC WORK-UP OF DEEP VENOUS THROMBOSIS OF THE LEG BETWEEN 1999 AND 2004
Buller H.R.	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
Büller H.R.	-	FLUID LOSS, COAGULATION ACTIVATION AND AIR TRAVEL
Buller H.R.	-	FAMILY HISTORY, DEEP VENOUS THROMBOSIS AND THROMBOPHILIA
Bullorsky E.	-	EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT
	-	PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS
Bulman D.E.	-	IDENTIFICATION OF A LOCUS FOR THE QUEBEC PLATELET DISORDER USING GENETIC LINKAGE ANALYSIS
Bultelle F.	-	CD36 AND SRA GENE EXPRESSION IN HUMAN CAROTID ENDARTERECTOMY LESIONS
Bunte R.	-	NOVEL MODELS OF THROMBOPHILIA RESULT IN SPONTANEOUS PERIPHERAL THROMBOSIS AND PREGNANCY-RELATED COMPLICATIONS
Buöen Stenmo C.	-	EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS
Buonamici P.	-	CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
	-	LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
Bura A.	-	PLATELET MICROPARTICLES LEVELS AND PREVALENCE OF ANTIPROTHROMBIN AND ANTI-BETA-2-GLYCOPROTEIN I ANTIBODIES IN THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
	-	LATE BREAKING CLINICAL TRIAL: ANTICOAGULANT CLINICS-BASED SHARED-CARE VERSUS GENERAL PRACTITIONERS MANAGEMENT OF ORAL ANTICOAGULANTS: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY
	-	LACK OF ENDOTHELIAL DYSFUNCTION IN THROMBOANGIITIS OBLITERANS
Burgess C.	-	PLATELET FUNCTION TESTING IN CHILDREN UNDER 1 YEAR
	-	ADAMTS 13 IN NON-THROMBOTIC THROMBOCYTOPENIC PURPURA CONDITIONS
Burgreen G.W.	-	CHARACTERIZATION OF A NEW METHOD TO ASSESS PLATELET ACTIVATION AND ERYTHROCYTE LYSIS DURING EXPOSURE TO PATHOPHYSIOLOGICAL SHEAR STRESS
Buriachkovskaia L.I.	-	MODULATION OF PLATELET REACTIVITY BY ERYTHROCYTES IN CORONARY ARTERY DISEASE PATIENTS TAKING ASPIRIN
Burke D.	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Burke F.	-	THROMBOSTATIN FM19 - A THROMBIN RECEPTOR ACTIVATION ANTAGONIST
Burkhardt N.	-	RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR BINDS RAPIDLY TO FACTOR XA
Burlova-Vasilieva N.N.K.	-	THE INFLUENCE OF STREPTOKINASE ON PLATELETS
Burnet E.	-	THE SPLENIC MICRO-ENVIRONMENT AND FVIII-VWF INTERACTION ARE DETERMINANTS OF THE IMMUNOGENIC PRESENTATION OF FVIII BY DENDRITIC CELLS
Burnett E.	-	IMMUNOGLOBULIN ISOTYPES AND FUNCTIONAL ANTI-FVIII ANTIBODIES IN RESPONSE TO FVIII TREATMENT IN TWO STRAINS OF HEMOPHILIA A MICE
	-	PRECLINICAL PHARMACOLOGY OF AV513 INCLUDING ORAL EFFICACY IN SEVERE HEMOPHILIA A DOGS
	-	ANTI-CD3 IN COMBINATION WITH NASAL FVIII-A2 DOMAIN DECREASES FVIII INHIBITORS
	-	ENHANCED TOLEROGENIC PRESENTATION OF FVIII BY ANDROGRAPHOLIDE-TREATED IMMATURE DENDRITIC CELLS
	-	IMMUNE TOLERANCE INDUCTION TO FVIII IN HEMOPHILIA A MICE USING SUBCUTANEOUSLY IMPLANTED FVIII GENE-MODIFIED ENDOTHELIAL PROGENITOR CELLS
Burnouf T.	-	ORIENTIA TSUTSUGAMUSHI INFECTION (SCRUB TYPHUS) IS ASSOCIATED WITH AN INFRACLINICAL ACTIVATION OF THE COAGULATION SYSTEM BUT NOT WITH AN ACTIVATION OF ENDOTHELIAL CELLS
	-	TRITON X-100 IS RESPONSIBLE FOR THE LOSS OF ALPHA2-ANTIPLASMIN INHIBITORY ACTIVITY IN SOLVENT-DETERGENT TREATED PLASMA
Burns P.	-	DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
	-	INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
	-	THE EFFECT OF APHERESIS ON DONORS' PLATELETS
Buryachkovskaya L.I.	-	CIRCULATING PROPLATELETS IN HEALTHY SUBJECTS AND PATIENTS
Burysek L.	-	THROMBIN STIMULATION AMPLIFIES MONOCYTIC/ENDOTHELIAL CELL CROSS-TALK AND SUBSEQUENT MCP-1 RELEASE THROUGH FRACTALKINE BINDING
Bus E.B.	-	JAK2-V617F IS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM
Busciantella N.	-	RAPID INCREASE OF EXPRESSION OF INDUCIBLE CYCLOOXYGENASE (COX-2) IN MONOCYTES OF PATIENTS WITH TYPE II DIABETES MELLITUS (T2DM) EXPOSED IN VIVO TO HYPERGLYCEMIC SPIKES
Busetto R.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Bush L.	-	PROTEIN C ACTIVATOR (PCA) INTERRUPTION OF THROMBUS PROPAGATION WITHOUT ANTIHEMOSTATIC SIDE EFFECT IN PRIMATES
	-	PROTEIN C ACTIVATOR (PCA) TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME OF EXPERIMENTAL THROMBOTIC ISCHEMIC STROKE IN MICE
Bussel J.	-	ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
Butenas S.	-	THROMBIN GENERATION PROFILES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE: A COMPUTATIONAL ANALYSIS
	-	FACTOR XIA (FXIA) AND TISSUE FACTOR (TF) ACTIVITY IN PLASMA OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
	-	THE INFLUENCE OF VON WILLEBRAND FACTOR (VWF) ON FACTOR VIII (FVIII) ACTIVITY IN PLASMA
Butler S.T.	-	EFFICIENT SECRETION OF BIOENGINEERED COAGULATION FACTOR VIII INTO THE MILK OF TRANSGENIC ANIMALS
Butler J.J.	-	A POTENTIAL SOURCE OF ERRONEOUS RESULTS ON AUTOMATED COAGULATION ANALYSERS - AN OBSERVATIONAL STUDY
Butta N.V.	-	CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
Butta N.	-	INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS
Buurman W.A.	-	ACTIVE SITE INHIBITED FACTOR VIIA HAS A PROTECTIVE ROLE IN RENAL ISCHEMIA/REPERFUSION INJURY VIA ANTI-INFLAMMATORY MECHANISMS
Buyue Y.	-	THE HEPARIN-BINDING EXOSITE IS CRITICAL TO ALLOSTERIC ACTIVATION OF FACTOR IXA IN THE INTRINSIC TENASE COMPLEX:
Byams V.R.	-	QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID
	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
	-	BASELINE QUALTIY OF LIFE (QOL) IN HEMOPHILIA PATIENTS RECEIVING CARE AT U.S. CENTERS
Bychkovskaya I.B.	-	AN INCREASE OF CELL LETHALITY IN IRRADIATED VASCULAR ENDOTHELIUM AND PROBLEM OF HAEMOSTASIS
Bydlowski S.	-	DELAYED ONSET OF LOW MOLECULAR WEIGHT HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN A CARDIAC PATIENT
Bykowska K.	-	"IMPACT R" - A NEW SCREENING TOOL FOR VON WILLEBRAND DISEASE?
	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 4G/4G GENOTYPE MAY INCREASE THE RISK OF THROMBOSIS IN SUBSET OF PATIENTS WITH PROTHROMBIN G20210A GENE MUTATION
	-	WHAT DOES HIGH PREVALANCE OF FACTOR V LEIDEN MUTATION IN POLISH SEVERE HAEMOPHILIACS MEAN?
Bylitova J.	-	INFLUENCE OF CYP2C9 GENETIC POLYMORPHISMS ON METABOLIC CLEARANCE, WARFARIN MAINTENANCE DOSE AND BLEEDING COMPLICATIONS IN RUSSIAN PATIENTS
Byrd S.	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Byrne M.	-	PROCOAGULANT EFFECTS OF NEOADJUVANT CHEMORADIATION FOR OESOPHAGEAL CANCER
	-	PROCOAGULANT EFFECTS OF NEOADJUVANT CHEMORADIATION FOR OESOPHAGEAL CANCER
Byrne B.	-	ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Bysted B.V.	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
Byström B.	-	DALTEPARIN SHORTENS HUMAN LABOR

| ISTH 2009